FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patrick Walsh

Research Profile

Disorders

Procedures

Prostatectomy

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Phillip M Pierorazio; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
Patrick C Walsh
How surgical innovation reduced death and suffering from prostate cancer.
Stacy Loeb; Lia Losonczy; Jeffrey Tosoian; Angela Gupta; Patrick C Walsh
Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patrick Walsh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Phillip M Pierorazio; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
BJU international 2013;111(5):753-60.
2013: Patrick C Walsh
How surgical innovation reduced death and suffering from prostate cancer.
The Journal of craniofacial surgery 2013;24(1):49-50.
2013: Stacy Loeb; Lia Losonczy; Jeffrey Tosoian; Angela Gupta; Patrick C Walsh
Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?
Current opinion in urology 2013;23(1):2-4.
2013: Jianfeng Xu; Siqun L Zheng; Kimberly A Zuhlke; Joan E Bailey-Wilson; Nicola J Camp; Geraldine Cancel-Tassin; Lisa A Cannon-Albright; John D Carpten; William J Catalona; Kathleen Cooney; Olivier Cussenot; Melissa S DeRycke; Doug Easton; Ros Eeles; William D Foulkes; Graham G Giles; Henrik Grönberg; Nancy Hamel; John L Hopper; Chih-Lin Hsieh; Sarah D Isaacs; William B Isaacs; Anna M Johnson; Zsofia Kote-Jarai; Ethan M Lange; Elisa Ledet; Lingyi Lu; Manuel Luedeke; Lovise Mahle; Christiane Maier; Diptasri Mandal; Shannon K McDonnell; Pal Moller; Elaine A Ostrander; Isaac J Powell; Daniel Schaid; Johanna Schleutker; Daniela Seminara; Gianluca Severi; Janet L Stanford; Teuvo Tammela; Craig C Teerlink; Stephen N Thibodeau; Walther Vogel; Tiina Wahlfors; Patrick C Walsh; Zhong Wang; Alice S Whittemore; Fredrik Wiklund; Kathleen E Wiley
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Human genetics 2013;132(1):5-14.
2013: John B Eifler; Jonathan I Epstein; Zhaoyang Feng; Misop Han; Elizabeth B Humphreys; Brian M Lin; Michael T Partin; Bruce J Trock; Patrick C Walsh; Alan W Partin
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.
BJU international 2013;111(1):22-9.
2012: H Ballentine Carter; Donald S Coffey; William G Nelson; Alan W Partin; Eric A Singer; Bruce J Trock; Robert W Veltri; Patrick C Walsh; Jonathan I Epstein
Gleason score 6 adenocarcinoma: should it be labeled as cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4294-6.
2012: Patrick C Walsh
Re: A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
The Journal of urology 2012;188(6):2227-8.
2012: Patrick C Walsh
Re: Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials.
The Journal of urology 2012;188(6):2226-7.
2012: Patrick C Walsh
Re: Radical prostatectomy versus observation for localized prostate cancer.
The Journal of urology 2012;188(6):2225-6.
2012: Jeffrey K Mullins; Bruce J Trock; Patrick C Walsh; Jonathan I Epstein; Zhaoyong Feng; Stacy Loeb
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.
The Journal of urology 2012;188(6):2219-24.
2012: Heather J Chalfin; Michael Dinizo; Zhaoyong Feng; Elizabeth Humphreys; Alan W Partin; Bruce J Trock; Patrick C Walsh; Misop Han
Impact of surgical margin status on prostate-cancer-specific mortality.
BJU international 2012;110(11):1684-9.
2012: Patrick C Walsh
How Charles Huggins made his Nobel prize winning discovery--in his own words: an historic audio recording. Interviewed by Willard Goodwin and Elmer Bell.
The Prostate 2012;72(16):1718.
2012: Siobhan Sutcliffe; Patrick C Walsh; Lori J Sokoll; Steven B Cersovsky; Debra J Elliott; Remington Lee Nevin; Ratna Pakpahan; Elizabeth A Platz
Prostate-specific antigen concentration in young men: new estimates and review of the literature.
BJU international 2012;110(11):1627-35.
2012: Patrick C Walsh
Re: Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
The Journal of urology 2012;188(5):1768-9.
2012: Patrick C Walsh
Re: Prostate-specific antigen concentration in young men: new estimates and review of the literature.
The Journal of urology 2012;188(5):1768.
2012: Patrick C Walsh
Re: Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.
The Journal of urology 2012;188(5):1767.
2012: Patrick C Walsh
Re: An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.
The Journal of urology 2012;188(4):1183.
2012: Patrick C Walsh
Re: The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.
The Journal of urology 2012;188(4):1182-3.
2012: Patrick C Walsh
Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
The Journal of urology 2012;188(4):1181.
2012: Phillip M Pierorazio; Ashley E Ross; Patrick C Walsh; Jonathan I Epstein; Misop Han; Brian M Lin; Alan W Partin; Christian P Pavlovich; Edward M Schaeffer
Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.
BJU international 2012;110(8):1122-8.
2012: James L Mohler; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Stan Rosenfeld; Sandy Srinivas; Seth A Strope; Jonathan Tward; Przemyslaw Twardowski; Patrick C Walsh; Andrew J Armstrong; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas Farrington; Celestia S Higano; Maria Ho; Eric Mark Horwitz; Philip W Kantoff; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R MacVicar; Arnold W Malcolm; David Miller; Dorothy A Shead
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(9):1081-7.
2012: Patrick C Walsh
Re: Long-term results of an RTOG phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
The Journal of urology 2012;188(3):810-1.
2012: Patrick C Walsh
Re: Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
The Journal of urology 2012;188(3):810.
2012: Patrick C Walsh
Re: The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
The Journal of urology 2012;188(3):809.
2012: Ashley E Ross; Bruce J Trock; Patrick C Walsh; H Ballentine Carter; Zhaoyong Feng; Patricia Landis; Phillip M Pierorazio; Edward M Schaeffer
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
BJU international 2012;110(5):651-7.
2012: Patrick C Walsh
Re: Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
The Journal of urology 2012;188(2):431.
2012: Patrick C Walsh
Re: Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer.
The Journal of urology 2012;188(2):430-1.
2012: Patrick C Walsh
Re: Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
The Journal of urology 2012;188(2):429-30.
2012: Deborah R Kaye; GEORGES NETTO; Nilda Gonzalez-Roibon; Patrick C Walsh; Ronald Rodriguez
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy.
Urology 2012;80(2):247-9.
2012: William J Catalona; Anthony V D'Amico; William F Fitzgibbons; Omofolasade Kosoko-Lasaki; Stephen W Leslie; Henry T Lynch; Judd W Moul; Marc S Rendell; Patrick C Walsh
What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.
Annals of internal medicine 2012;157(2):137-8.
2012: Patrick C Walsh
Re: Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition.
The Journal of urology 2012;188(1):112-3.
2012: Patrick C Walsh
Re: Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
The Journal of urology 2012;188(1):111-2.
2012: Patrick C Walsh
Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
The Journal of urology 2012;188(1):110-1.
2012: Guangfu Jin; Zsofia Kote-Jarai; Ethan M Lange; Lingyi Lu; Christiane Maier; Shannon K McDonnell; Ingrid Oakley-Girvan; Elaine A Ostrander; Anna M Ray; Antje Rinckleb; Daniel J Schaid; Johanna Schleutker; Gianluca Severi; Janet L Stanford; Teuvo Tammela; Craig C Teerlink; Stephen N Thibodeau; Walther Vogel; Tiina Wahlfors; Patrick C Walsh; Alice S Whittemore; Fredrik Wiklund; Kathleen E Wiley; Jianfeng Xu; S Lilly Zheng; Kimberly A Zuhlke; Nicola J Camp; Geraldine Cancel-Tassin; Lisa A Cannon-Albright; William J Catalona; Kathleen Cooney; Olivier Cussenot; Doug Easton; Ros Eeles; Christophe Egrot; Monica Emanuelsson; Liesel M Fitzgerald; William D Foulkes; Graham G Giles; Henrik Grönberg; Michelle Guy; John L Hopper; Chih-Lin Hsieh; Sarah D Isaacs; William B Isaacs
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Human genetics 2012;131(7):1095-103.
2012: Patrick C Walsh
Re: Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.
The Journal of urology 2012;187(6):2098.
2012: Patrick C Walsh
Re: Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.
The Journal of urology 2012;187(6):2097.
2012: Patrick C Walsh
Re: Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.
The Journal of urology 2012;187(6):2096-7.
2012: Patrick C Walsh; Allen D Seftel
Re: prediction of erectile function following treatment for prostate cancer.
The Journal of urology 2012;187(6):2094-6.
2012: Patrick C Walsh
Re: outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
The Journal of urology 2012;187(5):1641.
2012: Patrick C Walsh
Re: vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
The Journal of urology 2012;187(5):1640-1.
2012: Patrick C Walsh
Re: impact of meat consumption, preparation, and mutagens on aggressive prostate cancer.
The Journal of urology 2012;187(5):1639-40.
2012: Patrick C Walsh
Re: EPCA-2: a highly specific serum marker for prostate cancer.
The Journal of urology 2012;187(5):1639.
2012: Patrick C Walsh
Re: Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates.
The Journal of urology 2012;187(4):1269.
2012: Patrick C Walsh
Re: Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
The Journal of urology 2012;187(4):1267-8.
2012: Patrick C Walsh
Re: Germline mutations in HOXB13 and prostate cancer risk.
The Journal of urology 2012;187(4):1266-7.
2012: Patrick C Walsh
Re: contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA response and disease progression.
The Journal of urology 2012;187(3):912.
2012: Patrick C Walsh
Re: perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy.
The Journal of urology 2012;187(3):911.
2012: Patrick C Walsh
Re: radiotherapy and short-term androgen deprivation for localized prostate cancer.
The Journal of urology 2012;187(3):910.
2012: Patrick C Walsh
Re: long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
The Journal of urology 2012;187(3):909.
2012: Patrick C Walsh
Re: preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
The Journal of urology 2012;187(3):908.
2012: Lingyi Lu; Lovise Maehle; Christiane Maier; Shannon K McDonnell; Laura McIntosh; Pal Moller; Ingrid Oakley-Girvan; Elaine A Ostrander; Isaac J Powell; Daniel J Schaid; Johanna Schleutker; Daniela Seminara; Gianluca Severi; Claire Simpson; Janet L Stanford; Teuvo L J Tammela; Stephen N Thibodeau; Antoine Valeri; Walther Vogel; Patrick C Walsh; Alice S Whittemore; Fredrik Wiklund; Kathleen E Wiley; Jianfen Xu; S Lilly Zheng; Michael D Badzioch; Joan E Bailey-Wilson; Nicola J Camp; Geraldine Cancel-Tassin; Lisa A Cannon-Albright; John D Carpten; William J Catalona; Kathleen Cooney; Cheryl D Cropp; Olivier Cussenot; Kerry Deutsch; Douglas Easton; Steve Edwards; Ros Eeles; Monica Emanuelsson; Dallas R English; James M Farnham; Liesel M FitzGerald; William D Foulkes; Graham G Giles; Henrik Grönberg; Michelle Guy; Scott Hebbring; Brian T Helfand; Kathleen Herkommer; Josef Hoegel; John L Hopper; Chih-Lin Hsieh; Sarah D Isaacs; William B Isaacs; Bo Johanneson; Donghui Kan; Ethan M Lange
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.
The Prostate 2012;72(4):410-26.
2012: Patrick C Walsh
Re: orgasm-associated urinary incontinence and sexual life after radical prostatectomy.
The Journal of urology 2012;187(2):501.
2012: Patrick C Walsh
Re: stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes.
The Journal of urology 2012;187(2):500.
2012: Patrick C Walsh
Re: suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
The Journal of urology 2012;187(2):499.
2012: Patrick C Walsh
Re: should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
The Journal of urology 2012;187(2):498-9.
2012: Charles M Ewing; Kathleen E Wiley; Kimberly A Zuhlke; Waibhav D Tembe; Dorhyun Johng; Guifang Yan; Vijayalakshmi Shanmugam; David W Craig; James E Montie; William B Isaacs; Christiane M Robbins; Sarah D Isaacs; Chris Bizon; Anna M Ray; Yunfei Wang; Tyler Izatt; S Lilly Zheng; Marta Gielzak; Shripad Sinari; Alan W Partin; John D Carpten; Patrick C Walsh; Ethan M Lange; Jianfeng Xu; Kathleen Cooney
Germline mutations in HOXB13 and prostate-cancer risk.
The New England journal of medicine 2012;366(2):141-9.
2012: Joan E Bailey-Wilson; Sylvia Bochum; Nicola J Camp; Geraldine Cancel-Tassin; Lisa A Cannon-Albright; John D Carpten; Erica J Childs; Kathleen Cooney; Cheryl D Cropp; Olivier Cussenot; Kerry Deutsch; Latchezar Dimitrov; Douglas Easton; Steve Edwards; Rosalind Eeles; Monica Emanuelsson; Dallas R English; James M Farnham; William D Foulkes; Asha George; Graham G Giles; Henrik Grönberg; Michelle Guy; Scott Hebbring; Josef Hoegel; John L Hopper; Chih-Lin Hsieh; Sarah D Isaacs; William B Isaacs; Danielle M Karyadi; Ethan M Lange; Lovise Mæhle; Christiane Maier; Shannon K McDonnell; Laura McIntosh; Pål Møller; Ingrid Oakley-Girvan; Elaine A Ostrander; Isaac J Powell; Daniel J Schaid; Johanna Schleutker; Gianluca Severi; Janet L Stanford; Stephen N Thibodeau; Antoine Valeri; Patrick C Walsh; Alice S Whittemore; Fredrik Wiklund; Kathleen E Wiley; Jianfeng Xu; Teuvo L J Tammela; Michael D Badzioch
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.
BMC medical genetics 2012;13():46.
2012: Patrick C Walsh
Re: Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
The Journal of urology 2012;187(1):144-5.
2012: Patrick C Walsh
Re: A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.
The Journal of urology 2012;187(1):143.
2012: Patrick C Walsh
Re: Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
The Journal of urology 2012;187(1):142.
2012: Patrick C Walsh
Re: Smoking and prostate cancer survival and recurrence.
The Journal of urology 2012;187(1):141-2.
2012: Emmanuel S Antonarakis; Elizabeth B Humphreys; Patrick C Walsh; Michael A Carducci; Zhaoyong Feng; Alan W Partin; Bruce J Trock; Mario A Eisenberger
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
BJU international 2012;109(1):32-9.
2011: Patrick C Walsh
Re: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
The Journal of urology 2011;186(6):2254-5.
2011: Patrick C Walsh
Re: Abiraterone and increased survival in metastatic prostate cancer.
The Journal of urology 2011;186(6):2253-4.
2011: Patrick C Walsh
Re: salvage radiation in men after prostate-specific antigen failure and the risk of death.
The Journal of urology 2011;186(5):1876.
2011: Patrick C Walsh
Re: radical prostatectomy versus watchful waiting in early prostate cancer.
The Journal of urology 2011;186(5):1875.
2011: Patrick C Walsh
Re: disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-rotterdam after 11 years of follow-up.
The Journal of urology 2011;186(5):1874.
2011: Antoun Toubaji; Patrick C Walsh; Alan W Partin; Elizabeth A Platz; Roula Albadine; Alcides Chaux; Angelo M DeMarzo; Jonathan I Epstein; Michael C Haffner; Misop Han; William B Isaacs; Tamara LEVIN Lotan; Alan K Meeker; George Netto
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(11):1511-20.
2011: Stacy Loeb; Ashley Ross; Bruce J Trock; Zhaoyong Feng; Elizabeth B Humphreys; Patrick C Walsh
Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
The Journal of urology 2011;186(2):500-5.
2011: Jeffrey J Tosoian; Bruce J Trock; Patricia Landis; Zhaoyong Feng; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; H Ballentine Carter
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2185-90.
2011: Corinne E Joshu; Alison M Mondul; Cari L Meinhold; Elizabeth B Humphreys; Misop Han; Patrick C Walsh; Elizabeth A Platz
Cigarette smoking and prostate cancer recurrence after prostatectomy.
Journal of the National Cancer Institute 2011;103(10):835-8.
2011: Patrick C Walsh
Re: interval cancers in the antwerp European randomised study of screening for prostate cancer study, using a 6 year screening interval.
The Journal of urology 2011;185(5):1707.
2011: Patrick C Walsh
Re: Suicide Risk in Men With Prostate-Specific Antigen-Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study From PCBaSe Sweden.
The Journal of urology 2011;185(5):1706-7.
2011: Patrick C Walsh
Re: association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.
The Journal of urology 2011;185(5):1705-6.
2011: Patrick C Walsh
Re: prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
The Journal of urology 2011;185(5):1705.
2011: Patrick C Walsh
Re: impact of common medications on serum total prostate-specific antigen levels: analysis of the national health and nutrition examination survey.
The Journal of urology 2011;185(5):1704.
2011: Phillip M Pierorazio; Ashley E Ross; Edward M Schaeffer; Jonathan I Epstein; Misop Han; Patrick C Walsh; Alan W Partin
A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
The Journal of urology 2011;185(5):1691-7.
2011: Patrick C Walsh
Re: comorbidity and mortality results from a randomized prostate cancer screening trial.
The Journal of urology 2011;185(4):1274-5.
2011: Patrick C Walsh
Re: regulator sues pomegranate juice maker.
The Journal of urology 2011;185(4):1277-8.
2011: Patrick C Walsh
Re: Increased Cancer Risks for Relatives of Very Early-Onset Breast Cancer Cases With and Without BRCA1 and BRCA2 Mutations.
The Journal of urology 2011;185(4):1277.
2011: Patrick C Walsh
Re: effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the combination of avodart and tamsulosin trial.
The Journal of urology 2011;185(4):1276-7.
2011: Patrick C Walsh
Re: FDA panel votes against drugs said to prevent prostate cancer.
The Journal of urology 2011;185(4):1275-6.
2011: Alison M Mondul; Misop Han; Elizabeth B Humphreys; Cari L Meinhold; Patrick C Walsh; Elizabeth A Platz
Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery.
The Journal of urology 2011;185(4):1268-73.
2011: Corinne E Joshu; Alison M Mondul; Andy Menke; Cari Meinhold; Misop Han; Elizabeth B Humphreys; Stephen J Freedland; Patrick C Walsh; Elizabeth A Platz
Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.
Cancer prevention research (Philadelphia, Pa.) 2011;4(4):544-51.
2011: Scott E Eggener; Peter T Scardino; Patrick C Walsh; Misop Han; Alan W Partin; Bruce J Trock; Zhaoyong Feng; David P Wood; James A Eastham; Ofer Yossepowitch; Danny M Rabah; Michael W Kattan; Changhong Yu; Eric A Klein; Andrew J Stephenson
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
The Journal of urology 2011;185(3):869-75.
2011: Patrick C Walsh
Re: The Gleason Score of Tumor at the Margin in Radical Prostatectomy is Predictive of Biochemical Recurrence.
The Journal of urology 2011;185(2):516-7.
2011: Patrick C Walsh
Re: breast and prostate cancer: familial associations.
The Journal of urology 2011;185(2):515.
2011: Patrick C Walsh
Re: does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?
The Journal of urology 2011;185(2):515-6.
2011: Bruce J Trock; Patrick C Walsh
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.
Cancer 2011;117(3):656; author reply 656.
2011: Patrick C Walsh
Re: comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
The Journal of urology 2011;185(1):141.
2011: Patrick C Walsh
Re: years of potential life lost caused by prostate cancer deaths in the United States-projection from 2004 through 2050.
The Journal of urology 2011;185(1):141-2.
2011: Patrick C Walsh
Re: the relationship between prostate-specific antigen and prostate cancer risk: the prostate biopsy collaborative group.
The Journal of urology 2011;185(1):140.
2011: Patrick C Walsh
Re: Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/ml.
The Journal of urology 2011;185(1):139.
2010: Huihui Ye; Patrick C Walsh; Jonathan I Epstein
Skeletal muscle involvement by limited Gleason score 6 adenocarcinoma of the prostate on needle biopsy is not associated with adverse findings at radical prostatectomy.
The Journal of urology 2010;184(6):2308-12.
2010: Misop Han; Bruce J Trock; Alan W Partin; Elizabeth B Humphreys; Trinity J Bivalacqua; THOMAS GUZZO; Patrick C Walsh
The impact of preoperative erectile dysfunction on survival after radical prostatectomy.
BJU international 2010;106(11):1612-7.
2010: Patrick C Walsh
Urological oncology: prostate cancer.
The Journal of urology 2010;184(5):1982-5.
2010: Wilmer B Roberts; Kenneth Tseng; Patrick C Walsh; Misop Han
Critical appraisal of management of rectal injury during radical prostatectomy.
Urology 2010;76(5):1088-91.
2010: Phillip M Pierorazio; THOMAS GUZZO; Misop Han; Trinity J Bivalacqua; Jonathan I Epstein; Edward M Schaeffer; Mark P Schoenberg; Patrick C Walsh; Alan W Partin
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen.
Urology 2010;76(3):715-21.
2010: Phillip M Pierorazio; Elizabeth B Humphreys; Patrick C Walsh; Alan W Partin; Misop Han
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians.
BJU international 2010;106(6):791-5.
2010: Stacy Loeb; Edward M Schaeffer; Bruce J Trock; Jonathan I Epstein; Elizabeth B Humphreys; Patrick C Walsh
What are the outcomes of radical prostatectomy for high-risk prostate cancer?
Urology 2010;76(3):710-4.
2010: Stacy Loeb; Danil V Makarov; Edward M Schaeffer; Elizabeth B Humphreys; Patrick C Walsh
Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.
The Journal of urology 2010;184(1):157-61.
2010: Ashley E Ross; Stacy Loeb; Patricia Landis; Alan W Partin; Jonathan I Epstein; Anna Kettermann; Zhaoyong Feng; H Ballentine Carter; Patrick C Walsh
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2810-6.
2010: Bruce J Trock; Patrick C Walsh
Re: Radiation therapy after radical prostatectomy: impact on metastasis and survival S. A. Boorjian, R. J. Karnes, P. L. Crispen, L. J. Rangel, E. J. Bergstralh and M. L. Blute J Urol 2009; 182: 2708-2715.
The Journal of urology 2010;183(6):2466-7; author reply 2467.
2010: Stacy Loeb; Jonathan I Epstein; Elizabeth B Humphreys; Patrick C Walsh
Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?
BJU international 2010;105(11):1510-3.
2010: G Bryce Christensen; Agnes B Baffoe-Bonnie; Asha George; Isaac J Powell; Joan E Bailey-Wilson; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Maehle; Pal Moller; Ros Eeles; Douglas Easton; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Jianfeng Xu; Janet L Stanford; Bo Johanneson; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; William B Isaacs; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Daniel J Schaid; Ethan M Lange; Kathleen Cooney; Teuvo L J Tammela; Johanna Schleutker; Thomas Paiss; Christiane Maier; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; James M Farnham; Lisa A Cannon-Albright; Nicola J Camp
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.
The Prostate 2010;70(7):735-44.
2010: Patrick C Walsh
Chemoprevention of prostate cancer.
The New England journal of medicine 2010;362(13):1237-8.
2010: Patrick C Walsh
Is high-grade prostate cancer easier to find in smaller prostates because there is more high-grade disease to find?--letter.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1690; author reply 1690.
2010: Jianfeng Xu; S Lilly Zheng; Sarah D Isaacs; Kathy E Wiley; Fredrik Wiklund; Jielin Sun; A Karim Kader; Ge Li; Lina D Purcell; Seong-Tae Kim; Fang-Chi Hsu; Pär Stattin; Jonas Hugosson; Jan Adolfsson; Patrick C Walsh; Jeffrey M. Trent; David Duggan; John D Carpten; Henrik Grönberg; William B Isaacs
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(5):2136-40.
2010: Edward M Schaeffer; Stacy Loeb; Patrick C Walsh
The case for open radical prostatectomy.
The Urologic clinics of North America 2010;37(1):49-55, Table of Contents.
2010: Matthew Nielsen; Bruce J Trock; Patrick C Walsh
Salvage or adjuvant radiation therapy: counseling patients on the benefits.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(2):228-37.
2010: James Mohler; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony D'Amico; James A Eastham; Charles A Enke; Daniel George; Eric Mark Horwitz; Robert P Huben; Philip Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Gary Macvicar; Elizabeth R Plimack; Julio Pow-Sang; Mack Roach; Eric Rohren; Bruce J Roth; Dennis C Shrieve; Matthew R Smith; Sandy Srinivas; Przemyslaw Twardowski; Patrick C Walsh
NCCN clinical practice guidelines in oncology: prostate cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(2):162-200.
2010: Phillip M Pierorazio; Jonathan I Epstein; Elizabeth B Humphreys; Misop Han; Patrick C Walsh; Alan W Partin
The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warranted.
The Journal of urology 2010;183(1):151-7.
2009: Patrick C Walsh
Stop a killer before it's too late.
U.S. news & world report 2009;146(11):18.
2009: Stacy Loeb; Anna Kettermann; H Ballentine Carter; Luigi Ferrucci; E Jeffrey Metter; Patrick C Walsh
Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging.
The Journal of urology 2009;182(4):1458-62.
2009: A Karim Kader; Jielin Sun; Sarah D Isaacs; Kathy E Wiley; Guifang Yan; Seong-Tae Kim; Helen Fedor; Angelo M DeMarzo; Jonathan I Epstein; Patrick C Walsh; Alan W Partin; Bruce J Trock; S Lilly Zheng; Jianfeng Xu; William B Isaacs
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
The Prostate 2009;69(11):1195-205.
2009: Patrick C Walsh
Three considerations before advising 5-alpha-reductase inhibitors for chemoprevention.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):e22; author reply e23.
2009: Lingyi Lu; Jielin Sun; Sarah D Isaacs; Kathleen E Wiley; Shelly Smith; Kristen Pruett; Yi Zhu; Zheng Zhang; Fredrik Wiklund; Henrik Grönberg; Patrick C Walsh; Bao-Li Chang; S Lilly Zheng; William B Isaacs; Jianfeng Xu
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(7):2132-6.
2009: Jianfeng Xu; Adam S Kibel; Jennifer Hu; Aubrey R Turner; Kristen Pruett; S Lilly Zheng; Jielin Sun; Sarah D Isaacs; Kathleen E Wiley; Seong-Tae Kim; Fang-Chi Hsu; William Wu; Frank M Torti; Patrick C Walsh; Bao-Li Chang; William B Isaacs
Prostate cancer risk associated loci in African Americans.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(7):2145-9.
2009: Stacy Loeb; H Ballentine Carter; Patrick C Walsh; William B Isaacs; Anna Kettermann; Toshiko Tanaka; Luigi Ferrucci; E Jeffrey Metter
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level.
The Journal of urology 2009;182(1):101-4; discussion 105.
2009: Patrick C Walsh
2008 Whitmore Lecture: Radical prostatectomy--where we were and where we are going.
Urologic oncology 2009;27(3):246-50.
2009: Stacy Loeb; Edward M Schaeffer; Daniel W Chan; H Ballentine Carter; Patrick C Walsh; Lori J Sokoll
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
Urology 2009;73(5):947-9.
2009: Fang-Chi Hsu; Jielin Sun; Fredrik Wiklund; Sarah D Isaacs; Kathy E Wiley; Lina D Purcell; Zhengrong Gao; Pär Stattin; Yi Zhu; Seong-Tae Kim; Zheng Zhang; Wennuan Liu; Bao-Li Chang; Patrick C Walsh; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; Jianfeng Xu; S Lilly Zheng
A novel prostate cancer susceptibility locus at 19q13.
Cancer research 2009;69(7):2720-3.
2009: Patrick C Walsh
Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
The Journal of urology 2009;181(3):1499; author reply 1499-500.
2008: Matthew Nielsen; Edward M Schaeffer; Penny Marschke; Patrick C Walsh
High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy.
The Journal of urology 2008;180(6):2557-64; discussion 2564.
2008: Patrick C Walsh
Perfecting nerve-sparing radical prostatectomy: sailing in uncharted waters.
The Canadian journal of urology 2008;15(5):4230-2.
2008: Jielin Sun; Siqun Lilly Zheng; Fredrik Wiklund; Sarah D Isaacs; Lina D Purcell; Zhengrong Gao; Fang-Chi Hsu; Seong-Tae Kim; Wennuan Liu; Yi Zhu; Pär Stattin; Hans-Olov Adami; Kathleen E Wiley; Latchezar Dimitrov; Jishan Sun; Tao Li; Aubrey R Turner; Tamara S Adams; Jan Adolfsson; Jan-Erik Johansson; James Lowey; Bruce J Trock; Alan W Partin; Patrick C Walsh; Jeffrey M. Trent; David Duggan; John Carpten; Bao-Li Chang; Henrik Grönberg; William B Isaacs; Jianfeng Xu
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
Nature genetics 2008;40(10):1153-5.
2008: Stacy Loeb; Anna Kettermann; H Ballentine Carter; Luigi Ferrucci; E Jeffrey Metter; Patrick C Walsh
Does prostate growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging.
The Journal of urology 2008;180(4):1314-7; discussion 1317.
2008: Jianfeng Xu; Sarah D Isaacs; Jielin Sun; Ge Li; Kathleen E Wiley; Yi Zhu; Fang-Chi Hsu; Fredrik Wiklund; Aubrey R Turner; Tamara S Adams; Wennuan Liu; Bruce J Trock; Alan W Partin; Baoli Chang; Patrick C Walsh; Henrik Grönberg; William B Isaacs; Siqun Zheng
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5819-24.
2008: Jielin Sun; Bao-Li Chang; Sarah D Isaacs; Kathy E Wiley; Fredrik Wiklund; Pär Stattin; David Duggan; John D Carpten; Bruce J Trock; Alan W Partin; Patrick C Walsh; Henrik Grönberg; Jianfeng Xu; William B Isaacs; S Lilly Zheng
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
The Prostate 2008;68(12):1257-62.
2008: Matthew Nielsen; Danil V Makarov; Elizabeth B Humphreys; Leslie A Mangold; Alan W Partin; Patrick C Walsh
Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Urology 2008;72(2):389-93; discussion 394-5.
2008: David J Hernandez; Matthew Nielsen; Misop Han; Bruce J Trock; Alan W Partin; Patrick C Walsh; Jonathan I Epstein
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.
Urology 2008;72(1):172-6.
2008: Patrick C Walsh
How this doctor could save your mojo. Interview by Lawrence A Armour.
Fortune 2008;157(13):107, 108, 110.
2008: Bruce J Trock; Misop Han; Stephen J Freedland; Elizabeth B Humphreys; Theodore L DeWeese; Alan W Partin; Patrick C Walsh
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
JAMA : the journal of the American Medical Association 2008;299(23):2760-9.
2008: Stacy Loeb; David J Hernandez; Leslie A Mangold; Elizabeth B Humphreys; Marilyn Agro; Patrick C Walsh; Alan W Partin; Misop Han
Progression after radical prostatectomy for men in their thirties compared to older men.
BJU international 2008;101(12):1503-6.
2008: Jielin Sun; Lina Purcell; Zhengrong Gao; Sarah D Isaacs; Kathy E Wiley; Fang-Chi Hsu; Wennuan Liu; David Duggan; John D Carpten; Henrik Grönberg; Jianfeng Xu; Bao-Li Chang; Alan W Partin; Patrick C Walsh; William B Isaacs; S Lilly Zheng
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
The Prostate 2008;68(7):691-7.
2008: Jielin Sun; Ethan M Lange; Sarah D Isaacs; Wennuan Liu; Kathy E Wiley; Leslie A Lange; Henrik Gronberg; David Duggan; John D Carpten; Patrick C Walsh; Jianfeng Xu; Bao-Li Chang; William B Isaacs; S Lilly Zheng
Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
The Prostate 2008;68(5):489-97.
2008: Michael Müntener; Jonathan I Epstein; David J Hernandez; Mark L Gonzalgo; Leslie A Mangold; Elizabeth B Humphreys; Patrick C Walsh; Alan W Partin; Matthew Nielsen
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.
European urology 2008;53(4):767-75; discussion 775-6.
2008: Julius Gudmundsson; Patrick Sulem; Thorunn Rafnar; Jon T Bergthorsson; Andrei Manolescu; Daniel Gudbjartsson; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Thorarinn Blondal; Margret Jakobsdottir; Simon N Stacey; Jelena Kostic; Kari T Kristinsson; Birgitta Birgisdottir; Shyamali Ghosh; Droplaug N Magnusdottir; Steinunn Thorlacius; Gudmar Thorleifsson; S Lilly Zheng; Jielin Sun; Bao-Li Chang; J Bradford Elmore; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Brian Yaspan; Fredrik Wiklund; Par Stattin; Sara Lindström; Hans-Olov Adami; Shannon K McDonnell; Daniel J Schaid; Julie M Cunningham; Liang Wang; James R Cerhan; Jennifer L St Sauver; Sara D Isaacs; Kathleen E Wiley; Alan W Partin; Patrick C Walsh; Sonia Polo; Manuel Ruiz-Echarri; Sebastian Navarrete; Fernando Fuertes; Berta Saez; Javier Godino; Philip C Weijerman; Dorine W Swinkels; Katja K Aben; J Alfred Witjes; Brian K Suarez; Brian T Helfand; Michael L Frigge; Kristleifur Kristjansson; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jianfeng Xu; Henrik Gronberg; Jeffrey R Smith; Stephen N Thibodeau; William B Isaacs; William J Catalona; Jose I Mayordomo; Lambertus A Kiemeney; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; kari stefansson
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
Nature genetics 2008;40(3):281-3.
2008: Danil V Makarov; Elizabeth B Humphreys; Leslie A Mangold; Michael A Carducci; Alan W Partin; Mario A Eisenberger; Patrick C Walsh; Bruce J Trock
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy.
The Journal of urology 2008;179(1):156-61; discussion 161-2.
2007: Patrick C Walsh; Theodore L DeWeese; Mario A Eisenberger
Clinical practice. Localized prostate cancer.
The New England journal of medicine 2007;357(26):2696-705.
2007: David Duggan; Siqun L Zheng; Michele Knowlton; Debbie Benitez; Latchezar Dimitrov; Fredrik Wiklund; Christiane Robbins; Sarah D Isaacs; Yu Cheng; Ge Li; Jielin Sun; Bao-Li Chang; Leslie Marovich; Kathleen E Wiley; Katarina Bälter; Pär Stattin; Hans-Olov Adami; Marta Gielzak; Guifang Yan; Jurga Sauvageot; Wennuan Liu; Jin Woo Kim; Eugene R Bleecker; Deborah A Meyers; Bruce J Trock; Alan W Partin; Patrick C Walsh; William B Isaacs; Henrik Grönberg; Jianfeng Xu; John D Carpten
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Journal of the National Cancer Institute 2007;99(24):1836-44.
2007: H Ballentine Carter; Anna Kettermann; Christopher A Warlick; E Jeffrey Metter; Patricia Landis; Patrick C Walsh; Jonathan I Epstein
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.
The Journal of urology 2007;178(6):2359-64; discussion 2364-5.
2007: S Lilly Zheng; Jielin Sun; Yu Cheng; Ge Li; Fang-Chi Hsu; Yi Zhu; Bao-Li Chang; Wennuan Liu; Jin Woo Kim; Aubrey R Turner; Marta Gielzak; Guifang Yan; Sarah D Isaacs; Kathy E Wiley; Jurga Sauvageot; Huann-Sheng Chen; Robin Gurganus; Leslie A Mangold; Bruce J Trock; Henrik Gronberg; David Duggan; John D Carpten; Alan W Partin; Patrick C Walsh; Jianfeng Xu; William B Isaacs
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Journal of the National Cancer Institute 2007;99(20):1525-33.
2007: Ai-Ying Chuang; Matthew Nielsen; David J Hernandez; Patrick C Walsh; Jonathan I Epstein
The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1306-10.
2007: Ahmed Magheli; Soroush Rais-Bahrami; Hugh J Peck; Patrick C Walsh; Jonathan I Epstein; Bruce J Trock; Mark L Gonzalgo
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1311-5.
2007: James Mohler; Richard J Babaian; Robert R Bahnson; Barry Boston; Anthony V D'Amico; James A Eastham; Ralph J Hauke; Robert P Huben; Philip W Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Chris Logothetis; Gary MacVicar; Alan Pollack; Julio Pow-Sang; Mack Roach; Howard Sandler; Dennis C Shrieve; Sandhya Srinivas; Przemyslaw Twardowski; Donald A Urban; Patrick C Walsh
Prostate cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):650-83.
2007: Danil V Makarov; Bruce J Trock; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Urology 2007;69(6):1095-101.
2007: Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Agnes B Baffoe-Bonnie; Asha George; Isaac J Powell; Joan E Bailey-Wilson; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Maehle; Pal Moller; Ros Eeles; Douglas Easton; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Jianfeng Xu; Janet L Stanford; Bo Johanneson; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Daniel J Schaid; Ethan M Lange; Kathleen Cooney; Teuvo L J Tammela; Johanna Schleutker; Thomas Paiss; Christiane Maier; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; William B Isaacs
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.
Human molecular genetics 2007;16(11):1271-8.
2007: Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario A Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin
Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1765-71.
2007: Patrick C Walsh
The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy.
The Journal of urology 2007;177(5):1632-5.
2007: Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; kari stefansson
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Nature genetics 2007;39(5):631-7.
2007: Stephen J Freedland; Alan W Partin; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh
Radical prostatectomy for clinical stage T3a disease.
Cancer 2007;109(7):1273-8.
2006: Patrick C Walsh
Re: The Prostate Cancer Prevention Trial: design, biases and interpretation of study results. P. J. Goodman, I. M. Thompson, Jr., C. M. Tangen, J. J. Crowley, L. G. Ford and C. A. Coltman, Jr., J Urol, 175: 2234-2242, 2006.
The Journal of urology 2006;176(6 Pt 1):2744; author reply 2744.
2006: Daniel J Schaid; Shannon K McDonnell; Katherine E Zarfas; Julie M Cunningham; Scott Hebbring; Stephen N Thibodeau; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; Michael Badzioch; Tim BISHOP; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Michelle Guy; Chih-lin Hsieh; Jerry Halpern; Raymond R Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Ethan M Lange; Lindsey A Ho; Jennifer L Beebe; David P Wood Jr; Kathleen Cooney; Daniela Seminara; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Björn-Anders Jonsson; Henrik Grönberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; William J Catalona; Brian K Suarez; Kimberly A Roehl
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.
Human genetics 2006;120(4):471-85.
2006: Danil V Makarov; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh; Alan W Partin; Jonathan I Epstein; Stephen J Freedland
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
The Journal of urology 2006;176(2):554-8.
2006: Matthew Nielsen; Misop Han; Leslie A Mangold; Elizabeth B Humphreys; Patrick C Walsh; Alan W Partin; Stephen J Freedland
Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center.
The Journal of urology 2006;176(2):515-9.
2006: Patrick C Walsh
Re: Long-term effects of finasteride on prostate specific antigen levels: results from the Prostate Cancer Prevention Trial.
The Journal of urology 2006;176(1):409-10; author reply 410.
2006: Sabine Rohrmann; MARGARET D FALLIN; William F Page; Terry Reed; Alan W Partin; Patrick C Walsh; Elizabeth A Platz
Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins.
Epidemiology (Cambridge, Mass.) 2006;17(4):419-27.
2006: Junyan Xu; Jurga Sauvageot; Charles M Ewing; Jielin Sun; Wennuan Liu; Sarah D Isaacs; Kathy E Wiley; Lina Diaz; S Lilly Zheng; Patrick C Walsh; William B Isaacs
Germline ATBF1 mutations and prostate cancer risk.
The Prostate 2006;66(10):1082-5.
2006: Bao-Li Chang; Ethan M Lange; Latchezar Dimitrov; Christopher J Valis; Elizabeth M Gillanders; Leslie A Lange; Kathy E Wiley; Sarah D Isaacs; Fredrik Wiklund; Agnes B Baffoe-Bonnie; Carl D Langefeld; S Lilly Zheng; Mika P Matikainen; Tarja Ikonen; Henna Fredriksson; Teuvo Tammela; Patrick C Walsh; Joan E Bailey-Wilson; Johanna Schleutker; Henrik Gronberg; Kathleen Cooney; William B Isaacs; Edward Suh; Jeffrey M. Trent; Jianfeng Xu
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.
Human genetics 2006;118(6):716-24.
2006: Sabine Rohrmann; MARGARET D FALLIN; William F Page; Terry Reed; Alan W Partin; Patrick C Walsh; Elizabeth A Platz
Re: "Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish twin registry".
International journal of cancer. Journal international du cancer 2006;118(3):785.
2006: Mark L Gonzalgo; Patrick J Bastian; Leslie A Mangold; Bruce J Trock; Jonathan I Epstein; Patrick C Walsh; Alan W Partin
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
Urology 2006;67(1):115-9.
2006: S Lilly Zheng; Jeong-Ho Ju; Bao-Li Chang; Elizabeth Ortner; Jielin Sun; Sarah D Isaacs; Jishang Sun; Kathy E Wiley; Wennuan Liu; Micheas Zemedkun; Patrick C Walsh; James A Ferretti; James M Gruschus; William B Isaacs; Edward P Gelmann; Jianfeng Xu
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Cancer research 2006;66(1):69-77.
2005: Christopher L Wu; Andrew J Rowlingson; Alan W Partin; Murray A Kalish; Genevieve E Courpas; Patrick C Walsh; Lee A Fleisher
Correlation of postoperative pain to quality of recovery in the immediate postoperative period.
Regional anesthesia and pain medicine 2005;30(6):516-22.
2005: Matthew Nielsen; Patrick C Walsh
Systematic detection and repair of subclinical inguinal hernias at radical retropubic prostatectomy.
Urology 2005;66(5):1034-7.
2005: Patrick C Walsh
The association of body mass index and prostate-specific antigen in a population-based study.
The Journal of urology 2005;174(5):1825.
2005: Patrick C Walsh
Observed effect of age and body mass index on total and complexed PSA: analysis from a National Screening Program.
The Journal of urology 2005;174(5):1825-6.
2005: Patrick C Walsh
Serum levels of phytanic acid are associated with prostate cancer risk.
The Journal of urology 2005;174(5):1824.
2005: Patrick C Walsh
Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
The Journal of urology 2005;174(5):1824-5.
2005: Patrick C Walsh
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
The Journal of urology 2005;174(5):1823-4.
2005: Patrick C Walsh
Re: Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
The Journal of urology 2005;174(4 Pt 1):1500-1; author reply 1501.
2005: Patrick C Walsh
Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
The Journal of urology 2005;174(4 Pt 1):1294-5.
2005: Patrick C Walsh
Estimated impact of the prostate cancer prevention trial on population mortality.
The Journal of urology 2005;174(4 Pt 1):1293.
2005: Patrick C Walsh
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.
The Journal of urology 2005;174(4 Pt 1):1293-4.
2005: Patrick C Walsh
20-year outcomes following conservative management of clinically localized prostate cancer.
The Journal of urology 2005;174(4 Pt 1):1292-3.
2005: Patrick C Walsh
Radical prostatectomy versus watchful waiting in early prostate cancer.
The Journal of urology 2005;174(4 Pt 1):1291-2.
2005: Stephen J Freedland; Leslie A Mangold; Patrick C Walsh; Alan W Partin
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy.
The Journal of urology 2005;174(4 Pt 1):1276-81; discussion 1281; author reply 1281.
2005: Patrick C Walsh
Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.
The Journal of urology 2005;174(3):929.
2005: Patrick C Walsh
Risk of fracture after androgen deprivation for prostate cancer.
The Journal of urology 2005;174(3):929-30.
2005: Patrick C Walsh
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
The Journal of urology 2005;174(3):928-9.
2005: Bao-Li Chang; Sarah D Isaacs; Kathy E Wiley; Elizabeth M Gillanders; S Lilly Zheng; Deborah A Meyers; Patrick C Walsh; Jeffrey M. Trent; Jianfeng Xu; William B Isaacs
Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.
The Prostate 2005;64(4):356-61.
2005: Christopher L Wu; Alan W Partin; Andrew J Rowlingson; Murray A Kalish; Patrick C Walsh; Lee A Fleisher
Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy.
Urology 2005;66(2):366-70.
2005: Patrick C Walsh
Laparoscopic radical prostatectomy: is intact organ removal attainable? Study of margin status.
The Journal of urology 2005;174(2):568.
2005: Patrick C Walsh
Variation in course of cavernous nerve with special reference to details of topographic relationships near prostatic apex: histologic study using male cadavers.
The Journal of urology 2005;174(2):567.
2005: Patrick C Walsh
Extraperitoneal standard laparoscopic radical prostatectomy.
The Journal of urology 2005;174(2):567-8.
2005: Patrick C Walsh
Anatomical studies of the neurovascular bundle and cavernosal nerves.
The Journal of urology 2005;174(2):566.
2005: Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; D Timothy Bishop; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Chih-Lin Hsieh; Jerry Halpern; Raymond N Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Stephen N Thibodeau; Shannon K McDonnell; Julie M Cunningham; Katherine E Zarfas; Scott Hebbring; Daniel J Schaid; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Michael Badzioch; Gail P Jarvik; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Ethan M Lange; Jennifer L Beebe; Caroline E Mohai; Kathleen Cooney; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo Lj Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Bjorn-Anders Jonsson; Henrik Gronberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; Daniela Seminara
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.
American journal of human genetics 2005;77(2):219-29.
2005: Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario A Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
JAMA : the journal of the American Medical Association 2005;294(4):433-9.
2005: Patrick C Walsh
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate. Cancer patients treated with radical prostatectomy.
The Journal of urology 2005;173(6):1967-8.
2005: Patrick C Walsh
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
The Journal of urology 2005;173(6):1966.
2005: Patrick C Walsh
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
The Journal of urology 2005;173(6):1966-7.
2005: Stephen J Freedland; William B Isaacs; Leslie A Mangold; Sindy K Yiu; Kelly A Grubb; Alan W Partin; Jonathan I Epstein; Patrick C Walsh; Elizabeth A Platz
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2883-8.
2005: Patrick C Walsh
Delayed intraoperative hydration limits blood loss during radical retropubic prostatectomy.
The Journal of urology 2005;173(4):1171.
2005: Patrick C Walsh
Alcohol consumption and risk of prostate cancer in middle-aged men.
The Journal of urology 2005;173(4):1170.
2005: Patrick C Walsh
Prostate cancer screening and mortality: a case-control study (United States).
The Journal of urology 2005;173(4):1170-1.
2005: Patrick C Walsh
Hedgehog signalling in prostate regeneration, neoplasia and metastasis.
The Journal of urology 2005;173(4):1169.
2005: Bao-Li Chang; Elizabeth M Gillanders; Sarah D Isaacs; Kathy E Wiley; Tamara Adams; Aubrey R Turner; S Lilly Zheng; Deborah A Meyers; John D Carpten; Patrick C Walsh; Jeffrey M. Trent; Jianfeng Xu; William B Isaacs
Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer.
Cancer letters 2005;219(2):177-82.
2005: Patrick C Walsh
Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.
The Journal of urology 2005;173(3):832.
2005: Patrick C Walsh
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
The Journal of urology 2005;173(3):831-2.
2005: Patrick C Walsh
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.
The Journal of urology 2005;173(3):830.
2005: Patrick C Walsh
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.
The Journal of urology 2005;173(3):830-1.
2005: Goutham Narla; Analisa Difeo; Helen L Reeves; Daniel J Schaid; Jennifer Hirshfeld; Eldad Hod; Amanda Katz; William B Isaacs; Scott J Hebbring; Akira Komiya; Shannon K McDonnell; Kathy E Wiley; Steven J Jacobsen; Sarah D Isaacs; Patrick C Walsh; S Lilly Zheng; Bao-Li Chang; Danielle M Friedrichsen; Janet L Stanford; Elaine A Ostrander; Arul M Chinnaiyan; Mark A Rubin; Jianfeng Xu; Stephen N Thibodeau; Scott L Friedman; John A Martignetti
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Cancer research 2005;65(4):1213-22.
2005: Toyonori Tsuzuki; David J Hernandez; Hakan Aydin; Bruce J Trock; Patrick C Walsh; Jonathan I Epstein
Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
The Journal of urology 2005;173(2):450-3.
2005: David J Hernandez; Jonathan I Epstein; Bruce J Trock; Toyonori Tsuzuki; H Ballentine Carter; Patrick C Walsh
Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?
The Journal of urology 2005;173(2):446-9.
2005: Patrick C Walsh
Re: Anatomical radical retropubic prostatectomy: detailed description of the surgical technique.
The Journal of urology 2005;173(1):324.
2005: Patrick C Walsh
Proscar and Propecia--a therapeutic perspective.
The Journal of urology 2005;173(1):88.
2005: Patrick C Walsh
Residential sunlight exposure is associated with a decreased risk of prostate cancer.
The Journal of urology 2005;173(1):87.
2005: Patrick C Walsh
Cancer in US Air Force Veterans of the Vietnam War.
The Journal of urology 2005;173(1):87.
2005: Patrick C Walsh
Vitamin E supplements and risk of prostate cancer in U.S. men.
The Journal of urology 2005;173(1):87-8.
2004: Patrick C Walsh
BJU International June issue DVD.
BJU international 2004;94(7):1143.
2004: Ganesh S Palapattu; Mohamad E Allaf; Bruce J Trock; Jonathan I Epstein; Patrick C Walsh
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
The Journal of urology 2004;172(5 Pt 1):1860-4.
2004: Mohamad E Allaf; Ganesh S Palapattu; Bruce J Trock; H Ballentine Carter; Patrick C Walsh
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.
The Journal of urology 2004;172(5 Pt 1):1840-4.
2004: Masood A Khan; Leslie A Mangold; Jonathan I Epstein; John K Boitnott; Patrick C Walsh; Alan W Partin
Impact of surgical delay on long-term cancer control for clinically localized prostate cancer.
The Journal of urology 2004;172(5 Pt 1):1835-9.
2004: J Kellogg Parsons; Penny L Marschke; Patricia Maples; Patrick C Walsh
Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy.
Urology 2004;64(5):987-90.
2004: Dennis A Faith; William B Isaacs; James D Morgan; Helen Fedor; Jessica L Hicks; Leslie A Mangold; Patrick C Walsh; Alan W Partin; Elizabeth A Platz; Jun Luo; Angelo M DeMarzo
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
The Prostate 2004;61(3):215-27.
2004: Albert M Ong; Li-Ming Su; Ioannis M Varkarakis; Takeshi Inagaki; Richard E Link; Sam B Bhayani; Alexandru Patriciu; Barbara J Crain; Patrick C Walsh
Nerve sparing radical prostatectomy: effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model.
The Journal of urology 2004;172(4 Pt 1):1318-22.
2004: Hakan Aydin; Toyonori Tsuzuki; David Hernandez; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression.
Urology 2004;64(3):551-5.
2004: Gregory A Hawkins; Bao-Li Chang; S Lilly Zheng; Sarah D Isaacs; Kathy E Wiley; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; Jianfeng Xu; William B Isaacs
Mutational analysis of PINX1 in hereditary prostate cancer.
The Prostate 2004;60(4):298-302.
2004: Elizabeth M Gillanders; Jianfeng Xu; Bao-Li Chang; Ethan M Lange; Fredrik Wiklund; Joan E Bailey-Wilson; Agnes B Baffoe-Bonnie; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Sarah D Isaacs; Kathy E Wiley; Caroline E Mohai; Mika P Matikainen; Teuvo L J Tammela; S Lilly Zheng; W Mark Brown; Annika Rökman; John D Carpten; Deborah A Meyers; Patrick C Walsh; Johanna Schleutker; Henrik Gronberg; Kathleen Cooney; William B Isaacs; Jeffrey M. Trent
Combined genome-wide scan for prostate cancer susceptibility genes.
Journal of the National Cancer Institute 2004;96(16):1240-7.
2004: Jianfeng Xu; Carl D Langefeld; S Lilly Zheng; Elizabeth M Gillanders; Bao-Li Chang; Sarah D Isaacs; Adrienne H Williams; Kathy E Wiley; Latchezar Dimitrov; Deborah A Meyers; Patrick C Walsh; Jeffrey M. Trent; William B Isaacs
Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
Human genetics 2004;115(3):255-62.
2004: Craig G Rogers; Bruce J Trock; Patrick C Walsh
Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results.
Urology 2004;64(1):148-51.
2004: Patrick C Walsh
Editor's comment.
BJU international 2004;93(9):I-II.
2004: Edward M Schaeffer; Jonathan I Epstein; Patrick C Walsh
Amyloidosis of the seminal vesicle and hematospermia.
The Journal of urology 2004;171(6 Pt 1):2382.
2004: Robert W Veltri; Masood A Khan; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Patrick C Walsh; Alan W Partin
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3465-73.
2004: Edward M Schaeffer; Patrick C Walsh
Risks of testosterone replacement.
The New England journal of medicine 2004;350(19):2004-6; author reply 2004-6.
2004: Stephen J Freedland; Alan W Partin; Jonathan I Epstein; Patrick C Walsh
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
Cancer 2004;100(8):1646-9.
2004: H Ballentine Carter; E Jeffrey Metter; James Wright; Patricia Landis; Elizabeth A Platz; Patrick C Walsh
Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study On Aging.
Journal of the National Cancer Institute 2004;96(7):557-8.
2004: Patrick C Walsh
Re: variation in continence and potency by definition.
The Journal of urology 2004;171(4):1635; author reply.
2004: Bao-Li Chang; S Lilly Zheng; Sarah D Isaacs; Kathy E Wiley; Aubrey Turner; Ge Li; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Cancer research 2004;64(6):1997-9.
2004: Srinivasan Yegnasubramanian; Jeanne Kowalski; Mark L Gonzalgo; Marianna Zahurak; Steven Piantadosi; Patrick C Walsh; G Steven Bova; Angelo M DeMarzo; William B Isaacs; William G Nelson
Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Cancer research 2004;64(6):1975-86.
2004: Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth M Gillanders; Suzanne Kolb; Kathy E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M. Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):1939-44.
2004: W M Brown; Ethan M Lange; H Chen; S Lilly Zheng; Baoli Chang; Kathy E Wiley; Sarah D Isaacs; Patrick C Walsh; William B Isaacs; Jianfeng Xu; Kathleen Cooney
Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
British journal of cancer 2004;90(2):510-4.
2004: Misop Han; Alan W Partin; David Y Chan; Patrick C Walsh
An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
The Journal of urology 2004;171(1):23-6.
2003: Glenn M Cannon; Patrick C Walsh; Alan W Partin; Charles R Pound
Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer.
Urology 2003;62 Suppl 1():2-8.
2003: Masood A Khan; Patrick C Walsh; M Craig Miller; Wesley D Bales; Jonathan I Epstein; Leslie A Mangold; Alan W Partin; Robert W Veltri
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
Cancer 2003;98(12):2583-91.
2003: Masood A Khan; H Ballentine Carter; Jonathan I Epstein; M Craig Miller; Patricia Landis; Patrick C Walsh; Alan W Partin; Robert W Veltri
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?
The Journal of urology 2003;170(6 Pt 1):2274-8.
2003: Jianfeng Xu; Elizabeth M Gillanders; Sarah D Isaacs; Bao-Li Chang; Kathy E Wiley; S Lilly Zheng; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Diana Freas-Lutz; Carol Markey; Deborah A Meyers; Patrick C Walsh; Jeffrey M. Trent; William B Isaacs
Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
The Prostate 2003;57(4):320-5.
2003: Susan V Harden; Harriette Sanderson; Steven Goodman; Alan W Partin; Patrick C Walsh; Jonathan I Epstein; David Sidransky
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.
Journal of the National Cancer Institute 2003;95(21):1634-7.
2003: Masood A Khan; Alan W Partin; Leslie A Mangold; Jonathan I Epstein; Patrick C Walsh
Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.
Urology 2003;62(5):866-71.
2003: Bao-Li Chang; S Lilly Zheng; Sarah D Isaacs; A Turner; Gregory A Hawkins; Kathy E Wiley; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer.
British journal of cancer 2003;89(8):1524-9.
2003: Jun Luo; Thomas A Dunn; Charles M Ewing; Patrick C Walsh; William B Isaacs
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
The Prostate 2003;57(2):134-9.
2003: Bao-Li Chang; S Lilly Zheng; Sarah D Isaacs; Aubrey Turner; Gregory A Hawkins; Kathy E Wiley; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk.
International journal of cancer. Journal international du cancer 2003;106(3):375-8.
2003: S Lilly Zheng; Josyf C Mychaleckyj; Gregory A Hawkins; Sarah D Isaacs; Kathy E Wiley; Aubrey Turner; Bao-Li Chang; Chris Von Kap-Herr; John D Carpten; Mark J Pettenati; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
Mutation research 2003;528(1-2):45-53.
2003: Patrick C Walsh
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3.
The Journal of urology 2003;170(1):320.
2003: Patrick C Walsh
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
The Journal of urology 2003;170(1):319-20.
2003: Patrick C Walsh
Major postoperative complications secondary to use of the Bookwalter self-retaining retractor.
The Journal of urology 2003;170(1):319.
2003: Patrick C Walsh
Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experience.
The Journal of urology 2003;170(1):318-9.
2003: Patrick C Walsh
Laparoscopic radical prostatectomy: initial 70 cases at a U.S. university medical center.
The Journal of urology 2003;170(1):318.
2003: Patrick C Walsh
Substratification of stage T1c prostate cancer based on the probability of biochemical recurrence.
The Journal of urology 2003;170(1):317.
2003: Patrick C Walsh
Influence of prostate volume in the detection of prostate cancer.
The Journal of urology 2003;170(1):316-7.
2003: Patrick C Walsh
Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy.
The Journal of urology 2003;170(1):316.
2003: Patrick C Walsh
Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.
The Journal of urology 2003;170(1):315-6.
2003: Patrick C Walsh
Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study.
The Journal of urology 2003;170(1):315.
2003: Patrick C Walsh
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.
The Journal of urology 2003;170(1):314.
2003: Patrick C Walsh
Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China.
The Journal of urology 2003;170(1):314.
2003: Patrick C Walsh
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
The Journal of urology 2003;170(1):313-4.
2003: Patrick C Walsh
Screening for prostate cancer: recommendation and rationale.
The Journal of urology 2003;170(1):313.
2003: Patrick C Walsh
Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.
The Journal of urology 2003;170(1):312-3.
2003: Patrick C Walsh
Calcium intake and prostate cancer risk in a long-term aging study: The Baltimore Logitudinal Study of Aging.
The Journal of urology 2003;170(1):312.
2003: Masood A Khan; Misop Han; Alan W Partin; Jonathan I Epstein; Patrick C Walsh
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Urology 2003;62(1):86-91; discussion 91-2.
2003: Bao-Li Chang; S Lilly Zheng; Sarah D Isaacs; Aubrey R Turner; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
The Prostate 2003;56(1):37-44.
2003: Sabine Rohrmann; William W Roberts; Patrick C Walsh; Elizabeth A Platz
Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer.
The Prostate 2003;55(2):140-6.
2003: Mark L Gonzalgo; Patrick C Walsh
Balloon cuffing and management of the entrapped Foley catheter.
Urology 2003;61(4):825-7.
2003: Franklin C Lowe; John D McConnell; Perry B Hudson; Nicholas A Romas; Rex Boake; Michael Lieber; Mostafa Elhilali; Jack Geller; Juliane Imperto-McGinely; Gerald L Andriole; Reginald C Bruskewitz; Patrick C Walsh; Georg Bartsch; John N Nacey; Sukrut Shah; Frances Pappas; Amy Ko; Thomas Cook; Elizabeth Stoner; Joanne Waldstreicher
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
Urology 2003;61(4):791-6.
2003: Jay D Pearson; Hsien-Hsien Lei; Terri H beaty; Kathy E Wiley; Sarah D Isaacs; William B Isaacs; Elizabeth Stoner; Patrick C Walsh
Familial aggregation of bothersome benign prostatic hyperplasia symptoms.
Urology 2003;61(4):781-5.
2003: Patrick C Walsh
Altered cognitive function in men treated for prostate cancer with leutinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled study.
The Journal of urology 2003;169(4):1598.
2003: Patrick C Walsh
The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
The Journal of urology 2003;169(4):1597-8.
2003: Patrick C Walsh
Predictive factors of urinary retention following prostate brachytherapy.
The Journal of urology 2003;169(4):1597.
2003: Patrick C Walsh
Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile dysfunction.
The Journal of urology 2003;169(4):1596-7.
2003: Patrick C Walsh
(In)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.
The Journal of urology 2003;169(4):1596, 1597.
2003: Patrick C Walsh
Postoperative radiotherapy in 423 patients with pT30NO prostate cancer.
The Journal of urology 2003;169(4):1595, 1597.
2003: Patrick C Walsh
Defining sexual outcomes after treatment for localized prostate carcinoma.
The Journal of urology 2003;169(4):1594-5.
2003: Patrick C Walsh
Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiation.
The Journal of urology 2003;169(4):1593, 1594.
2003: Patrick C Walsh
Dietary supplement use in the Prostate Cancer Prevention trial: implications for prevention trials.
The Journal of urology 2003;169(4):1593.
2003: Patrick C Walsh
Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial.
The Journal of urology 2003;169(4):1592-3.
2003: Patrick C Walsh
Serum proteomic patterns for detection of prostate cancer.
The Journal of urology 2003;169(4):1592.
2003: Patrick C Walsh
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
The Journal of urology 2003;169(4):1591.
2003: Patrick C Walsh
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.
The Journal of urology 2003;169(4):1591.
2003: Patrick C Walsh
Germline mutations and sequence variants of macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
The Journal of urology 2003;169(4):1589-90.
2003: Patrick C Walsh
Quality of life after radical prostatectomy or watchful waiting.
The Journal of urology 2003;169(4):1588-9.
2003: Patrick C Walsh
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
The Journal of urology 2003;169(4):1588, 1589.
2003: Misop Han; Alan W Partin; Marianna Zahurak; Steven Piantadosi; Jonathan I Epstein; Patrick C Walsh
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
The Journal of urology 2003;169(2):517-23.
2003: William W Roberts; Elizabeth A Platz; Patrick C Walsh
Association of cigarette smoking with extraprostatic prostate cancer in young men.
The Journal of urology 2003;169(2):512-6; discussion 516.
2003: Jianfeng Xu; S Lilly Zheng; Akira Komiya; Josyf C Mychaleckyj; Sarah D Isaacs; Baoli Chang; Aubrey R Turner; Charles M Ewing; Kathy E Wiley; Gregory A Hawkins; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs
Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
American journal of human genetics 2003;72(1):208-12.
2002: Matthew B Gretzer; Jonathan I Epstein; Charles R Pound; Patrick C Walsh; Alan W Partin
Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence.
Urology 2002;60(6):1034-9.
2002: S Lilly Zheng; Bao-Li Chang; Dennis A Faith; Jill R Johnson; Sarah D Isaacs; Gregory A Hawkins; Aubrey Turner; Kathy E Wiley; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
Cancer research 2002;62(22):6485-8.
2002: Gregory A Hawkins; Scott D Cramer; S Lilly Zheng; Sarah D Isaacs; Kathy E Wiley; Bao-Li Chang; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk.
The Prostate 2002;53(3):175-8.
2002: Patrick C Walsh
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
The Journal of urology 2002;168(4 Pt 1):1643.
2002: Patrick C Walsh
The antisteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade. A double blind, randomized, placebo-controlled crossover study.
The Journal of urology 2002;168(4 Pt 1):1642-3.
2002: Patrick C Walsh
Variations in morbidity after radical prostatectomy.
The Journal of urology 2002;168(4 Pt 1):1642.
2002: Patrick C Walsh
The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients.
The Journal of urology 2002;168(4 Pt 1):1641.
2002: Patrick C Walsh
Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy.
The Journal of urology 2002;168(4 Pt 1):1641.
2002: Patrick C Walsh
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.
The Journal of urology 2002;168(4 Pt 1):1640.
2002: Patrick C Walsh
Large-scale randomized prostate cancer screening trials: program performance in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial.
The Journal of urology 2002;168(4 Pt 1):1639.
2002: Patrick C Walsh
A prospective study of physical activity and risk of prostate cancer in US physicians.
The Journal of urology 2002;168(4 Pt 1):1638-9.
2002: Patrick C Walsh
Survival of blacks and whites after a cancer diagnosis.
The Journal of urology 2002;168(4 Pt 1):1637-8.
2002: Patrick C Walsh
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.
The Journal of urology 2002;168(4 Pt 1):1637.
2002: Patrick C Walsh
Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.
The Journal of urology 2002;168(4 Pt 1):1636-7.
2002: Patrick C Walsh
Associations between hOGG1 sequence variants and prostate cancer susceptibility.
The Journal of urology 2002;168(4 Pt 1):1636.
2002: Patrick C Walsh
Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.
The Journal of urology 2002;168(4 Pt 1):1635-6.
2002: Patrick C Walsh
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
The Journal of urology 2002;168(4 Pt 1):1635.
2002: Patrick C Walsh
Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices.
The Journal of urology 2002;168(4 Pt 1):1634, 1635.
2002: Patrick C Walsh
A prospective study on the intake of animal products and risk of prostate cancer.
The Journal of urology 2002;168(4 Pt 1):1634, 1635.
2002: Matthew B Gretzer; Bruce J Trock; Misop Han; Patrick C Walsh
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
The Journal of urology 2002;168(4 Pt 1):1419-22.
2002: Jianfeng Xu; S Lilly Zheng; Akira Komiya; Josyf C Mychaleckyj; Sarah D Isaacs; Jennifer Hu; David Sterling; Ethan M Lange; Gregory A Hawkins; Aubrey Turner; Charles M Ewing; Dennis A Faith; Jill R Johnson; Hiroyoshi Suzuki; Piroska Bujnovszky; Kathleen E Wiley; Angelo M DeMarzo; G Steven Bova; Baoli Chang; M Craig Hall; David L McCullough; Alan W Partin; Vahan S Kassabian; John D Carpten; Joan E Bailey-Wilson; Jeffrey M. Trent; Jill Ohar; Eugene R Bleecker; Patrick C Walsh; William B Isaacs; Deborah A Meyers
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Nature genetics 2002;32(2):321-5.
2002: Patrick C Walsh
Surgery and the reduction of mortality from prostate cancer.
The New England journal of medicine 2002;347(11):839-40.
2002: Gregory A Hawkins; Josyf C Mychaleckyj; S Lilly Zheng; Dennis A Faith; Brian Kelly; Sarah D Isaacs; Kathy E Wiley; Bao-Li Chang; Charles M Ewing; Piroska Bujnovszky; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
Cancer genetics and cytogenetics 2002;137(1):1-7.
2002: Patrick C Walsh; Penny L Marschke
Intussusception of the reconstructed bladder neck leads to earlier continence after radical prostatectomy.
Urology 2002;59(6):934-8.
2002: Gloria Y F Ho; Michael Knapp; Diha Freije; William G Nelson; Jeffrey R Smith; John D Carpten; Joan E Bailey-Wilson; Terri H beaty; Gloria Petersen; Jianfeng Xu; Victor Kamensky; Patrick C Walsh; William B Isaacs
Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer families.
International journal of cancer. Journal international du cancer 2002;98(6):938-42.
2002: Jianfeng Xu; S Lilly Zheng; Aubrey Turner; Sarah D Isaacs; Kathy E Wiley; Gregory A Hawkins; Bao-Li Chang; Eugene R Bleecker; Patrick C Walsh; Deborah A Meyers; William B Isaacs
Associations between hOGG1 sequence variants and prostate cancer susceptibility.
Cancer research 2002;62(8):2253-7.
2002: Bao-Li Chang; S Lilly Zheng; Gregory A Hawkins; Sarah D Isaacs; Kathy E Wiley; Aubrey Turner; John D Carpten; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Cancer research 2002;62(6):1784-9.
2002: H Ballentine Carter; Patrick C Walsh; Patricia Landis; Jonathan I Epstein
Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.
The Journal of urology 2002;167(3):1231-4.
2002: Bao-Li Chang; S Lilly Zheng; Gregory A Hawkins; Sarah D Isaacs; Kathy E Wiley; Aubrey Turner; John D Carpten; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
Human genetics 2002;110(2):122-9.
2002: Gleen J Gormley; Elizabeth Stoner; Reginald C Bruskewitz; Julianne imperato-Mcginley; Patrick C Walsh; John D McConnell; Gerald L Andriole; Jack Geller; Bruce R Bracken; Joyce S Tenover; E Darracott Vaughan; Frances Pappas; Alice Taylor; Bruce Binkowitz; Jennifer Ng
The effect of finasteride in men with benign prostatic hyperplasia. 1992.
The Journal of urology 2002;167(2 Pt 2):1102-7; discussion 1108.
2002: Patrick C Walsh; Pieter J Donker
Impotence following radical prostatectomy: insight into etiology and prevention. 1982.
The Journal of urology 2002;167(2 Pt 2):1005-10.
2002: J Carpten; N Nupponen; S Isaacs; R Sood; C Robbins; Jianfeng Xu; M Faruque; T Moses; C Ewing; E Gillanders; P Hu; P Bujnovszky; I Makalowska; A Baffoe-Bonnie; D Faith; J Smith; Dietrich A Stephan; K Wiley; M Brownstein; D Gildea; B Kelly; R Jenkins; Galen Hostetter; M Matikainen; J Schleutker; K Klinger; T Connors; Y Xiang; Z Wang; Angelo M DeMarzo; Nickolas Papadopoulos; Olli Kallioniemi; Robert D Burk; Deborah A Meyers; H Grönberg; P Meltzer; R Silverman; J Bailey-Wilson; Patrick C Walsh; William B Isaacs; Jeffrey M. Trent
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
Nature genetics 2002;30(2):181-4.
2002: Kiaran J O'Malley; Charles R Pound; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy.
Urology 2002;59(1):85-90.
2001: Alan W Partin; Leslie A Mangold; D M Lamm; Patrick C Walsh; Jonathan I Epstein; Jay D Pearson
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
Urology 2001;58(6):843-8.
2001: Patrick C Walsh
Re: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized cancer.
The Journal of urology 2001;166(6):2321-2.
2001: B Chang; S L Zheng; Sarah D Isaacs; Kathy E Wiley; John D Carpten; Gregory A Hawkins; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer.
International journal of cancer. Journal international du cancer 2001;95(6):354-9.
2001: D A Barocas; Misop Han; Jonathan I Epstein; David Y Chan; Bruce J Trock; Patrick C Walsh; Alan W Partin
Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
Urology 2001;58(5):746-51.
2001: Jonathan I Epstein; Patrick C Walsh; H Ballentine Carter
Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease.
The Journal of urology 2001;166(5):1688-91.
2001: Patrick C Walsh
The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma.
The Journal of urology 2001;166(4):1581-2.
2001: Misop Han; Alan W Partin; Charles R Pound; Jonathan I Epstein; Patrick C Walsh
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.
The Urologic clinics of North America 2001;28(3):555-65.
2001: Patrick C Walsh; Theodore L DeWeese; Mario A Eisenberger
A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment.
The Journal of urology 2001;166(2):508-15; discussion 515-6.
2001: Misop Han; Alan W Partin; Steven Piantadosi; Jonathan I Epstein; Patrick C Walsh
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
The Journal of urology 2001;166(2):416-9.
2001: Jianfeng Xu; S Lilly Zheng; Gregory A Hawkins; Dennis A Faith; B Kelly; Sarah D Isaacs; Kathy E Wiley; Baoli Chang; Charles M Ewing; Piroska Bujnovszky; John D Carpten; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.
American journal of human genetics 2001;69(2):341-50.
2001: Jonathan I Epstein; Patrick C Walsh; H Ballentine Carter
Importance of posterolateral needle biopsies in the detection of prostate cancer.
Urology 2001;57(6):1112-6.
2001: William W Roberts; E J Bergstralh; M L Blute; J M Slezak; Michael A Carducci; Misop Han; Jonathan I Epstein; Mario A Eisenberger; Patrick C Walsh; Alan W Partin
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy.
Urology 2001;57(6):1033-7.
2001: Patrick C Walsh
Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy.
Urology 2001;57(6):1020-4.
2001: S L Zheng; Jianfeng Xu; Sarah D Isaacs; Kathy E Wiley; B Chang; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs
Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families.
Human genetics 2001;108(5):430-5.
2001: Jianfeng Xu; S Lilly Zheng; Baoli Chang; J R Smith; John D Carpten; O Colin Stine; Sarah D Isaacs; Kathy E Wiley; L Henning; Charles M Ewing; Piroska Bujnovszky; E R Bleeker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs
Linkage of prostate cancer susceptibility loci to chromosome 1.
Human genetics 2001;108(4):335-45.
2001: H Ballentine Carter; Patricia Landis; Jonathan I Epstein; Patrick C Walsh
Expectant management of prostate cancer with curative intent.
European urology 2001;39 Suppl 4():24.
2001: Misop Han; Steven Piantadosi; Marianna Zahurak; Lori J Sokoll; Daniel W Chan; Jonathan I Epstein; Patrick C Walsh; Alan W Partin
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Urology 2001;57(4):707-11.
2001: Jianfeng Xu; S Lilly Zheng; John D Carpten; Nina N Nupponen; Christiane M Robbins; J Mestre; Tracy Y Moses; Dennis A Faith; B D Kelly; Sarah D Isaacs; Kathy E Wiley; Charles M Ewing; Piroska Bujnovszky; Baoli Chang; Joan E Bailey-Wilson; Eugene R Bleecker; Patrick C Walsh; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
American journal of human genetics 2001;68(4):901-11.
2001: Patrick C Walsh; Penny L Marschke; William J Catalona; Herbert Lepor; S Martin; R P Myers; M S Steiner
Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons.
Urology 2001;57(3):491-4.
2001: Patrick C Walsh
Re: Radical prostatectomy: the value of preoperative, individually labeled apical biopsies.
The Journal of urology 2001;165(3):915.
2001: Misop Han; Charles R Pound; Steven R Potter; Alan W Partin; Jonathan I Epstein; Patrick C Walsh
Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
The Journal of urology 2001;165(3):864-6.
2001: Patrick C Walsh
Modern prostate brachytherapy: prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
The Journal of urology 2001;165(1):318-9.
2000: Misop Han; P B Snow; Jonathan I Epstein; Theresa Y Chan; K A Jones; Patrick C Walsh; Alan W Partin
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
Urology 2000;56(6):994-9.
2000: Steven R Potter; Leslie A Mangold; Matthew J Shue; D C Taylor; Kristin Lecksell; Jonathan I Epstein; Patrick C Walsh; Alan W Partin
Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.
Cancer 2000;89(12):2577-86.
2000: Robert R Bahnson; G E Hanks; R P Huben; Philip W Kantoff; J M Kozlowski; Michael Kuettel; P H Lange; C Logothetis; Julio Pow-Sang; M Roach; Howard Sandler; Peter T Scardino; R J Taylor; Donald A Urban; Patrick C Walsh; T G Wilson
NCCN Practice Guidelines for Prostate Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):111-9.
2000: M R Feneley; Patricia Landis; I Simon; E J Metter; C H Morrell; H Ballentine Carter; Patrick C Walsh
Today men with prostate cancer have larger prostates.
Urology 2000;56(5):839-42.
2000: Theresa Y Chan; Alan W Partin; Patrick C Walsh; Jonathan I Epstein
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.
Urology 2000;56(5):823-7.
2000: Michael L Blute; E J Bergstralh; Alan W Partin; Patrick C Walsh; Michael W Kattan; Peter T Scardino; James E Montie; Jay D Pearson; J M Slezak; Horst Zincke
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
2000: Patrick C Walsh
Re: radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.
The Journal of urology 2000;164(4):1322-3.
2000: Jonathan I Epstein; Alan W Partin; Steven R Potter; Patrick C Walsh
Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.
Urology 2000;56(2):283-8.
2000: William J Catalona; PC Southwick; Kevin Slawin; Alan W Partin; Michael K Brawer; RC Flanigan; A Patel; JP Richie; Patrick C Walsh; Peter T Scardino; PH Lange; GH Gasior; KG Loveland; KR Bray
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.
Urology 2000;56(2):255-60.
2000: Patrick C Walsh
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
The Journal of urology 2000;164(1):246-7.
2000: Patrick C Walsh
Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.
The Journal of urology 2000;164(1):242.
2000: Misop Han; Patrick C Walsh; Alan W Partin; Ronald Rodriguez
Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
The Journal of urology 2000;164(1):89-92.
2000: Ronald Rodriguez; Patrick C Walsh
Trousseau's syndrome in a patient with metastatic prostate cancer.
The Journal of urology 2000;163(6):1877.
2000: Patrick C Walsh
Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
The Journal of urology 2000;163(6):1802-7.
2000: William J Catalona; Alan W Partin; Kevin Slawin; C K Naughton; Michael K Brawer; RC Flanigan; JP Richie; A Patel; Patrick C Walsh; Peter T Scardino; PH Lange; Jean B deKernion; PC Southwick; KG Loveland; RE Parson; GH Gasior
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
Urology 2000;55(3):372-6.
2000: Patrick C Walsh; Penny L Marschke; D Ricker; Arthur L Burnett
Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy.
Urology 2000;55(1):62-7.
2000: Patrick C Walsh; Penny L Marschke; D Ricker; Arthur L Burnett
Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.
Urology 2000;55(1):58-61.
2000: Patrick C Walsh
Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE.
The Journal of urology 2000;163(1):370.
2000: Patrick C Walsh
Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
The Journal of urology 2000;163(1):364-5.
2000: Claus G Roehrborn; John McConnell; J Bonilla; S Rosenblatt; Perry B Hudson; Gholem H Malek; P F Schellhammer; Reginald C Bruskewitz; Alvin M Matsumoto; L H Harrison; H A Fuselier; Patrick C Walsh; J Roy; Gerald L Andriole; M Resnick; Joanne Waldstreicher
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.
The Journal of urology 2000;163(1):13-20.
1999: Mario A Eisenberger; Patrick C Walsh
Early androgen deprivation for prostate cancer?
The New England journal of medicine 1999;341(24):1837-8.
1999: Jonathan I Epstein; Patrick C Walsh; G Akingba; H Ballentine Carter
The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer.
The Journal of urology 1999;162(5):1649-52.
1999: PC Southwick; William J Catalona; Alan W Partin; Kevin Slawin; Michael K Brawer; RC Flanigan; A Patel; JP Richie; Patrick C Walsh; Peter T Scardino; PH Lange; GH Gasior; RE Parson; KG Loveland
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
The Journal of urology 1999;162(4):1346-51.
1999: CR Pound; O W Christens-Barry; Robin Gurganus; Alan W Partin; Patrick C Walsh
Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
The Journal of urology 1999;162(4):1337-40.
1999: M R Feneley; Patrick C Walsh
Incontinence after radical prostatectomy.
Lancet 1999;353(9170):2091-2.
1999: E P Wilkens; Diha Freije; J Xu; D R Nusskern; H Suzuki; Sarah D Isaacs; Kathy E Wiley; P Bujnovsky; Deborah A Meyers; Patrick C Walsh; William B Isaacs
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer.
The Prostate 1999;39(4):280-4.
1999: Charles R Pound; Alan W Partin; Mario A Eisenberger; Daniel W Chan; Jay D Pearson; Patrick C Walsh
Natural history of progression after PSA elevation following radical prostatectomy.
JAMA : the journal of the American Medical Association 1999;281(17):1591-7.
1999: G F Holmes; Patrick C Walsh; CR Pound; Jonathan I Epstein
Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy.
Urology 1999;53(4):752-6.
1999: Patrick C Walsh
Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma.
The Journal of urology 1999;161(1):357-8.
1999: Patrick C Walsh
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial.
The Journal of urology 1999;161(1):350-1.
1999: Claus F Eisenberger; Patrick C Walsh; Mario A Eisenberger; N H Chow; Alan W Partin; Jacek L Mostwin; Fray F Marshall; Jonathan I Epstein; Mark P Schoenberg
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer.
Urology 1999;53(1):175-9.
1998: Patrick C Walsh
Anatomic radical prostatectomy: evolution of the surgical technique.
The Journal of urology 1998;160(6 Pt 2):2418-24.
1998: Jonathan I Epstein; Daniel W Chan; Lori J Sokoll; Patrick C Walsh; J L Cox; H Rittenhouse; R Wolfert; H Ballentine Carter
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.
The Journal of urology 1998;160(6 Pt 2):2407-11.
1998: Pedram Argani; Patrick C Walsh; Jonathan I Epstein
Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone.
The Journal of urology 1998;160(6 Pt 1):2126-9.
1998: Jianfeng Xu; Deborah A Meyers; D Freije; S Isaacs; K Wiley; D Nusskern; C Ewing; E Wilkens; P Bujnovszky; G Steven Bova; Patrick C Walsh; William B Isaacs; J Schleutker; M Matikainen; T Tammela; T Visakorpi; Olli Kallioniemi; R Berry; D Schaid; A French; S McDonnell; J Schroeder; M Blute; S Thibodeau; H Grönberg; M Emanuelsson; J E Damber; A Bergh; B A Jonsson; J Smith; J Bailey-Wilson; J Carpten; Dietrich A Stephan; E Gillanders; I Amundson; T Kainu; D Freas-Lutz; A Baffoe-Bonnie; A Van Aucken; R Sood; Francis S Collins; M Brownstein; Jeffrey M. Trent
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Nature genetics 1998;20(2):175-9.
1998: F E Glover; Donald S Coffey; LL Douglas; H Russell; M Cadigan; T Tulloch; K Wedderburn; RL Wan; Timothy Baker; Patrick C Walsh
Familial study of prostate cancer in Jamaica.
Urology 1998;52(3):441-3.
1998: G Steven Bova; Alan W Partin; Sarah D Isaacs; B S Carter; Terri H beaty; William B Isaacs; Patrick C Walsh
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy.
The Journal of urology 1998;160(3 Pt 1):660-3.
1998: L R Miller; Alan W Partin; Daniel W Chan; Debra J Bruzek; Adrian S Dobs; Jonathan I Epstein; Patrick C Walsh
Influence of radical prostatectomy on serum hormone levels.
The Journal of urology 1998;160(2):449-53.
1998: Patrick C Walsh
Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.
The Journal of urology 1998;160(1):270-1.
1998: Patrick C Walsh
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
The Journal of urology 1998;160(1):265-6.
1998: Jonathan I Epstein; Charles R Pound; Alan W Partin; Patrick C Walsh
Disease progression following radical prostatectomy in men with Gleason score 7 tumor.
The Journal of urology 1998;160(1):97-100; discussion 101.
1998: TJ Polascik; Charles R Pound; Theodore L DeWeese; Patrick C Walsh
Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.
Urology 1998;51(6):884-9; discussion 889-90.
1998: F E Glover; Donald S Coffey; LL Douglas; M Cadogan; H Russell; T Tulloch; Timothy Baker; RL Wan; Patrick C Walsh
The epidemiology of prostate cancer in Jamaica.
The Journal of urology 1998;159(6):1984-6; discussion 1986-7.
1998: William J Catalona; Alan W Partin; Kevin Slawin; Michael K Brawer; RC Flanigan; A Patel; JP Richie; Jean B deKernion; Patrick C Walsh; Peter T Scardino; PH Lange; EN Subong; RE Parson; GH Gasior; KG Loveland; PC Southwick
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
JAMA : the journal of the American Medical Association 1998;279(19):1542-7.
1998: J Pannek; Harry G Rittenhouse; Daniel W Chan; Jonathan I Epstein; Patrick C Walsh; Alan W Partin
The use of percent free prostate specific antigen for staging clinically localized prostate cancer.
The Journal of urology 1998;159(4):1238-42.
1998: John D McConnell; Reginald C Bruskewitz; Patrick C Walsh; Gerald L Andriole; Michael Lieber; HL Holtgrewe; P Albertsen; Claus G Roehrborn; J Curtis Nickel; D Z Wang; A M Taylor; Joanne Waldstreicher
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
The New England journal of medicine 1998;338(9):557-63.
1998: Patrick C Walsh
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy.
The Journal of urology 1998;159(1):308-9.
1998: Jeffrey A Cadeddu; Alan W Partin; Theodore L DeWeese; Patrick C Walsh
Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy.
The Journal of urology 1998;159(1):173-7; discussion 177-8.
1997: Patrick C Walsh
Conflict of interest or widely held misconception?
Urology 1997;50(6):1028.
1997: William F Page; M M Braun; Alan W Partin; N Caporaso; Patrick C Walsh
Heredity and prostate cancer: a study of World War II veteran twins.
The Prostate 1997;33(4):240-5.
1997: H Grönberg; J Xu; J R Smith; John D Carpten; Sarah D Isaacs; Diha Freije; G Steven Bova; J E Danber; A Bergh; Patrick C Walsh; Francis S Collins; Jeffrey M. Trent; Deborah A Meyers; William B Isaacs
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
Cancer research 1997;57(21):4707-9.
1997: Patrick C Walsh; Alan W Partin
Family history facilitates the early diagnosis of prostate carcinoma.
Cancer 1997;80(9):1871-4.
1997: Jonathan I Epstein; Patrick C Walsh; Jurga Sauvageot; H Ballentine Carter
Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
The Journal of urology 1997;158(5):1886-90.
1997: H Grönberg; Sarah D Isaacs; J R Smith; John D Carpten; G Steven Bova; Diha Freije; J Xu; Deborah A Meyers; Francis S Collins; Jeffrey M. Trent; Patrick C Walsh; William B Isaacs
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.
JAMA : the journal of the American Medical Association 1997;278(15):1251-5.
1997: Patrick C Walsh
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.
The Journal of urology 1997;158(4):1623-4.
1997: Patrick C Walsh
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.
The Journal of urology 1997;158(4):1618-9.
1997: Patrick C Walsh
Screening for prostate cancer. American College of Physicians.
The Journal of urology 1997;158(4):1617.
1997: Jeffrey A Cadeddu; Alan W Partin; Jonathan I Epstein; Patrick C Walsh
Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Urology 1997;50(2):251-5.
1997: H Ballentine Carter; Jurga Sauvageot; Patrick C Walsh; Jonathan I Epstein
Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.
The Journal of urology 1997;157(6):2206-9.
1997: Alan W Partin; Michael W Kattan; EN Subong; Patrick C Walsh; Kirk J Wojno; JE Oesterling; Peter T Scardino; Jay D Pearson
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
1997: R Thiel; Jay D Pearson; Jonathan I Epstein; Patrick C Walsh; H Ballentine Carter
Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer.
Urology 1997;49(5):716-20.
1997: Charles R Pound; Alan W Partin; Jonathan I Epstein; Patrick C Walsh
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.
The Urologic clinics of North America 1997;24(2):395-406.
1997: Patrick C Walsh
Localized prostate cancer-mortality and morbidity.
The Journal of urology 1997;157(5):1773.
1997: Patrick C Walsh
Is prostate cancer screening analogous to lung cancer screening?
JAMA : the journal of the American Medical Association 1997;277(14):1121; author reply 1121-2.
1997: Patrick C Walsh
Re: Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer.
The Journal of urology 1997;157(3):965.
1997: Martin G Sanda; C B Doehring; Bruce Binkowitz; Terri H beaty; Alan W Partin; E Hale; Elizabeth Stoner; Patrick C Walsh
Clinical and biological characteristics of familial benign prostatic hyperplasia.
The Journal of urology 1997;157(3):876-9.
1997: Patrick C Walsh; J D Brooks
The Swedish prostate cancer paradox.
JAMA : the journal of the American Medical Association 1997;277(6):497-8.
1997: Charles R Pound; Patrick C Walsh; Jonathan I Epstein; Daniel W Chan; Alan W Partin
Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer.
World journal of urology 1997;15(6):373-7.
1996: J R Smith; Diha Freije; John D Carpten; Henrik Grönberg; Jianfeng Xu; Sarah D Isaacs; M J Brownstein; G Steven Bova; H Guo; P Bujnovszky; D R Nusskern; J E Damber; A Bergh; M Emanuelsson; Olli Kallioniemi; J Walker-Daniels; J E Bailey-Wilson; Terri H beaty; Deborah A Meyers; Patrick C Walsh; Francis S Collins; Jeffrey M. Trent; William B Isaacs
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.
Science (New York, N.Y.) 1996;274(5291):1371-4.
1996: Laurence H Baker; G Hanks; D Gershenson; Philip W Kantoff; P Lange; C Logothetis; H Sandler; Patrick C Walsh
NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.) 1996;10(11 Suppl):265-88.
1996: C B Doehring; Martin G Sanda; Alan W Partin; Jurga Sauvageot; H Juo; Terri H beaty; Jonathan I Epstein; G Hill; Patrick C Walsh
Histopathologic characterization of hereditary benign prostatic hyperplasia.
Urology 1996;48(4):650-3.
1996: Patrick C Walsh
Treatment of benign prostatic hyperplasia.
The New England journal of medicine 1996;335(8):586-7.
1996: T Niesel; Alan W Partin; Patrick C Walsh
Anatomic approach for placement of surgical drains after radical retropubic prostatectomy: long-term effects on postoperative pain.
Urology 1996;48(1):91-4.
1996: Jonathan I Epstein; Patrick C Walsh; Alfred P. Sanfilippo
Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy.
The American journal of surgical pathology 1996;20(7):851-7.
1996: Patrick C Walsh
Follow-up prostate cancer treatments after radical prostatectomy: a population-based study.
The Journal of urology 1996;156(1):301-2.
1996: Patrick C Walsh
The definition and preoperative prediction of clinically insignificant prostate cancer.
The Journal of urology 1996;156(1):300-1.
1996: Patrick C Walsh
Re: Quality of life: radical prostatectomy versus radiation therapy for prostate cancer.
The Journal of urology 1996;155(6):2038-9.
1996: Patrick C Walsh
RE: Prostate specific antigen after gonadal androgen withdrawal and deferred flutamide treatment.
The Journal of urology 1996;155(5):1705.
1996: Alan W Partin; S R Criley; EN Subong; H Zincke; Patrick C Walsh; J E Oesterling
Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.
The Journal of urology 1996;155(4):1336-9.
1996: Jonathan I Epstein; Alan W Partin; Jurga Sauvageot; Patrick C Walsh
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up.
The American journal of surgical pathology 1996;20(3):286-92.
1996: Mark P Schoenberg; L Kiemeney; Patrick C Walsh; Constance A Griffin; David Sidransky
Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma.
The Journal of urology 1996;155(3):1035-6.
1996: Mark P Schoenberg; Patrick C Walsh; D R Breazeale; Fray F Marshall; Jacek L Mostwin; Charles B Brendler
Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
The Journal of urology 1996;155(2):490-4.
1996: Patrick C Walsh
Re: Potency-sparing radical retropubic prostatectomy: a simplified anatomical approach.
The Journal of urology 1996;155(1):294.
1995: D M Quinlan; Alan W Partin; Patrick C Walsh
Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?
Urology 1995;46(3 Suppl A):77-82.
1995: Sarah D Isaacs; L A Kiemeney; A Baffoe-Bonnie; Terri H beaty; Patrick C Walsh
Risk of cancer in relatives of prostate cancer probands.
Journal of the National Cancer Institute 1995;87(13):991-6.
1995: TJ Polascik; Patrick C Walsh
Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function.
The Journal of urology 1995;154(1):150-2.
1995: H Ballentine Carter; Jay D Pearson; E Jeffrey Metter; Daniel W Chan; Reubin Andres; JL Fozard; W Rosner; Patrick C Walsh
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
The Prostate 1995;27(1):25-31.
1995: Patrick C Walsh
A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia.
The Journal of urology 1995;154(1):301.
1995: R R Berges; J Vukanovic; Jonathan I Epstein; M CarMichel; L Cisek; D E Johnson; Robert W Veltri; Patrick C Walsh; John T Isaacs
Implication of cell kinetic changes during the progression of human prostatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(5):473-80.
1995: Alan W Partin; Steven Piantadosi; Martin G Sanda; Jonathan I Epstein; Fray F Marshall; James L Mohler; Charles B Brendler; Patrick C Walsh; Jonathan W Simons
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.
Urology 1995;45(5):831-8.
1995: H Ballentine Carter; Jay D Pearson; Z Waclawiw; E J Metter; Daniel W Chan; Harry A Guess; Patrick C Walsh
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.
Urology 1995;45(4):591-6.
1995: Maureen A Riopel; TJ Polascik; Alan W Partin; Jurga Sauvageot; Patrick C Walsh; Jonathan I Epstein
Radical prostatectomy in men less than 50 years old.
Urologic oncology 1995;1(2):80-3.
1995: S I Bastacky; K J Wojno; Patrick C Walsh; M J Carmichael; Jonathan I Epstein
Pathological features of hereditary prostate cancer.
The Journal of urology 1995;153(3 Pt 2):987-92.
1995: M J Carmichael; Robert W Veltri; Alan W Partin; M C Miller; Patrick C Walsh; Jonathan I Epstein
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
The Journal of urology 1995;153(3 Pt 2):1015-9.
1994: Patrick C Walsh
The status of radical prostatectomy in the United States in 1993: where do we go from here?
The Journal of urology 1994;152(5 Pt 2):1816.
1994: Alan W Partin; W F Page; BR Lee; Martin G Sanda; R N Miller; Patrick C Walsh
Concordance rates for benign prostatic disease among twins suggest hereditary influence.
Urology 1994;44(5):646-50.
1994: Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
The Journal of urology 1994;152(5 Pt 2):1831-6.
1994: Jonathan I Epstein; Patrick C Walsh; Charles B Brendler
Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
The Journal of urology 1994;152(5 Pt 2):1721-9.
1994: Sean P Hedican; Patrick C Walsh
Postoperative bleeding following radical retropubic prostatectomy.
The Journal of urology 1994;152(4):1181-3.
1994: A R Sgrignoli; Patrick C Walsh; Gary D Steinberg; M S Steiner; Jonathan I Epstein
Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.
The Journal of urology 1994;152(4):1077-81.
1994: Patrick C Walsh
Radical prostatectomy: a procedure in evolution.
Seminars in oncology 1994;21(5):662-71.
1994: Patrick C Walsh
Prostate cancer kills: strategy to reduce deaths.
Urology 1994;44(4):463-6.
1994: Patrick C Walsh
Results of conservative management of clinically localized prostate cancer.
The Journal of urology 1994;152(1):255-6.
1994: Alan W Partin; Patrick C Walsh
Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
The Journal of urology 1994;152(1):172-3.
1994: M G Sanda; Terri H beaty; R E Stutzman; Barton Childs; Patrick C Walsh
Genetic susceptibility of benign prostatic hyperplasia.
The Journal of urology 1994;152(1):115-9.
1994: Jonathan I Epstein; M J Carmichael; Alan W Partin; Patrick C Walsh
Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications.
The Journal of urology 1994;151(6):1587-92.
1994: Alan W Partin; B R Lee; M Carmichael; Patrick C Walsh; Jonathan I Epstein
Radical prostatectomy for high grade disease: a reevaluation 1994.
The Journal of urology 1994;151(6):1583-6.
1994: Alan W Partin; Jay D Pearson; Patricia Landis; H Ballentine Carter; Charles R Pound; J Quentin Clemens; Jonathan I Epstein; Patrick C Walsh
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
Urology 1994;43(5):649-59.
1994: Jonathan I Epstein; Patrick C Walsh; M Carmichael; Charles B Brendler
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
JAMA : the journal of the American Medical Association 1994;271(5):368-74.
1994: Mark P Schoenberg; J M Hakimi; S Wang; G Steven Bova; Jonathan I Epstein; Kenneth H Fischbeck; William B Isaacs; Patrick C Walsh; Evelyn Barrack
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.
Biochemical and biophysical research communications 1994;198(1):74-80.
1994: Patrick C Walsh; Alan W Partin
Treatment of early stage prostate cancer: radical prostatectomy.
Important advances in oncology 1994;():211-23.
1994: Gleen J Gormley; J Ng; T Cook; Elizabeth Stoner; Harry A Guess; Patrick C Walsh
Effect of finasteride on prostate-specific antigen density.
Urology 1994;43(1):53-8; discussion 58-9.
1993: Patrick C Walsh
Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters.
Annals of internal medicine 1993;119(9):948-9.
1993: Alan W Partin; Charles R Pound; J Quentin Clemens; Jonathan I Epstein; Patrick C Walsh
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
The Urologic clinics of North America 1993;20(4):713-25.
1993: Patrick C Walsh
A decision analysis of alternative treatment strategies for clinically localized prostate cancer.
The Journal of urology 1993;150(4):1330-2.
1993: Patrick C Walsh
Disease-specific survival following routine prostate cancer screening by digital rectal examination.
The Journal of urology 1993;150(4):1328-9.
1993: L J Cisek; Patrick C Walsh
Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices.
Urology 1993;42(4):406-8.
1993: B S Carter; G Steven Bova; Terri H beaty; Gary D Steinberg; Barton Childs; William B Isaacs; Patrick C Walsh
Hereditary prostate cancer: epidemiologic and clinical features.
The Journal of urology 1993;150(3):797-802.
1993: G Steven Bova; B S Carter; M J G Bussemakers; M Emi; Y Fujiwara; Natasha Kyprianou; Stephen C Jacobs; J C Robinson; Jonathan I Epstein; Patrick C Walsh
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Cancer research 1993;53(17):3869-73.
1993: Arthur L Burnett; S L Tillman; T S Chang; Jonathan I Epstein; Charles J Lowenstein; D S Bredt; Solomon H Snyder; Patrick C Walsh
Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis.
The Journal of urology 1993;150(1):73-6.
1993: Jonathan I Epstein; M J Carmichael; G Pizov; Patrick C Walsh
Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup.
The Journal of urology 1993;150(1):135-41.
1993: Alan W Partin; J Yoo; H Ballentine Carter; Jay D Pearson; Daniel W Chan; Jonathan I Epstein; Patrick C Walsh
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
The Journal of urology 1993;150(1):110-4.
1993: Jonathan I Epstein; M Carmichael; Alan W Partin; Patrick C Walsh
Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
The Journal of urology 1993;149(6):1478-81.
1993: Jonathan I Epstein; G Pizov; Patrick C Walsh
Correlation of pathologic findings with progression after radical retropubic prostatectomy.
Cancer 1993;71(11):3582-93.
1993: Jonathan I Epstein; M Carmichael; Patrick C Walsh
Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis.
The Journal of urology 1993;149(5):1040-5.
1993: S I Bastacky; Patrick C Walsh; Jonathan I Epstein
Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate.
The American journal of surgical pathology 1993;17(4):336-41.
1993: D M Quinlan; R E Stutzman; C A Peters; Patrick C Walsh
Unilateral nerve-sparing radical prostatectomy and hemicystectomy in management of prostate sarcoma.
Urology 1993;41(4):308-10.
1993: JA Grass; Neal Sakima; M Valley; K Fischer; C Jackson; Patrick C Walsh; D L Bourke
Assessment of ketorolac as an adjuvant to fentanyl patient-controlled epidural analgesia after radical retropubic prostatectomy.
Anesthesiology 1993;78(4):642-8; discussion 21A.
1993: Patrick C Walsh
The effect of finasteride in men with benign prostatic hyperplasia.
The Journal of urology 1993;149(4):932-3.
1993: C M Tempany; Alan W Partin; Robert Harriman; S J Zinreich; Patrick C Walsh
The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia.
The Prostate 1993;22(1):39-42.
1992: Arthur L Burnett; Daniel W Chan; Charles B Brendler; Patrick C Walsh
The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
The Journal of urology 1992;148(6):1832-4.
1992: A Rahmouni; ANDREW YANG; C M Tempany; T Frenkel; Jonathan I Epstein; Patrick C Walsh; PK Leichner; C Ricci; Robert Harriman
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography.
Journal of computer assisted tomography 1992;16(6):935-40.
1992: Gleen J Gormley; Elizabeth Stoner; R C Bruskewitz; Julianne imperato-Mcginley; Patrick C Walsh; John D McConnell; Gerald L Andriole; J Geller; B R Bracken; J S Tenover
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
The New England journal of medicine 1992;327(17):1185-91.
1992: C B Brendler; Patrick C Walsh
The role of radical prostatectomy in the treatment of prostate cancer.
CA: a cancer journal for clinicians 1992;42(4):212-22.
1992: Jonathan I Epstein; Galina Pizov; Gary D Steinberg; H Ballentine Carter; R Pitcock; O A Armas; Alan W Partin; Patrick C Walsh
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
The Journal of urology 1992;148(1):87-91.
1992: H Ballentine Carter; Christopher H Morrell; Jay D Pearson; Larry J Brant; C C Plato; E Jeffrey Metter; Daniel W Chan; JL Fozard; Patrick C Walsh
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
Cancer research 1992;52(12):3323-8.
1992: H Ballentine Carter; Jay D Pearson; E Jeffrey Metter; Larry J Brant; Daniel W Chan; Reubin Andres; JL Fozard; Patrick C Walsh
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.
JAMA : the journal of the American Medical Association 1992;267(16):2215-20.
1992: B S Carter; Terri H beaty; Gary D Steinberg; Barton Childs; Patrick C Walsh
Mendelian inheritance of familial prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3367-71.
1992: Paul M Ness; D L Bourke; Patrick C Walsh
A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery.
Transfusion 1992;32(3):226-30.
1992: R N Borland; Patrick C Walsh
The management of rectal injury during radical retropubic prostatectomy.
The Journal of urology 1992;147(3 Pt 2):905-7.
1992: Patrick C Walsh
Why make an early diagnosis of prostate cancer.
The Journal of urology 1992;147(3 Pt 2):853-4.
1992: Paul M Ness; Patrick C Walsh; M Zahurak; M L Baldwin; Steven Piantadosi
Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood.
Transfusion 1992;32(1):31-6.
1991: C M Tempany; A D Rahmouni; Jonathan I Epstein; Patrick C Walsh; Robert Harriman
Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging.
Radiology 1991;181(1):107-12.
1991: J K Burgers; Randy J Nelson; D M Quinlan; Patrick C Walsh
Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats.
The Journal of urology 1991;146(2):463-8.
1991: Ulrike M Hamper; SHIELA SHETH; Patrick C Walsh; P M Holtz; Jonathan I Epstein
Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions.
Radiology 1991;180(1):101-4.
1991: M V Sadi; Patrick C Walsh; Evelyn Barrack
Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
Cancer 1991;67(12):3057-64.
1991: Ronald A Morton; M S Steiner; Patrick C Walsh
Cancer control following anatomical radical prostatectomy: an interim report.
The Journal of urology 1991;145(6):1197-200.
1991: E D Vaughan; Patrick C Walsh
Prostate Health Council.
Urology 1991;37(5):501.
1991: D M Quinlan; Jonathan I Epstein; B S Carter; Patrick C Walsh
Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles.
The Journal of urology 1991;145(5):998-1002.
1991: S S Bastacky; Patrick C Walsh; Jonathan I Epstein
Needle biopsy associated tumor tracking of adenocarcinoma of the prostate.
The Journal of urology 1991;145(5):1003-7.
1991: W N Christensen; G Steinberg; Patrick C Walsh; Jonathan I Epstein
Prostatic duct adenocarcinoma. Findings at radical prostatectomy.
Cancer 1991;67(8):2118-24.
1991: SHIELA SHETH; Ulrike M Hamper; Patrick C Walsh; P M Holtz; Jonathan I Epstein
Stage A adenocarcinoma of the prostate: transrectal US and sonographic-pathologic correlation.
Radiology 1991;179(1):35-9.
1991: M S Steiner; Ronald A Morton; Patrick C Walsh
Impact of anatomical radical prostatectomy on urinary continence.
The Journal of urology 1991;145(3):512-4; discussion 514-5.
1991: Fray F Marshall; Jacek L Mostwin; L C Radebaugh; Patrick C Walsh; Charles B Brendler
Ileocolic neobladder post-cystectomy: continence and potency.
The Journal of urology 1991;145(3):502-4.
1991: Ulrike M Hamper; SHIELA SHETH; Patrick C Walsh; P M Holtz; Jonathan I Epstein
Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation.
Radiology 1991;178(3):791-5.
1991: J P Weber; Patrick C Walsh; C A Peters; Jerry L Spivak
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men.
American journal of hematology 1991;36(3):190-4.
1991: D M Quinlan; Randy J Nelson; Patrick C Walsh
Cavernous nerve grafts restore erectile function in denervated rats.
The Journal of urology 1991;145(2):380-3.
1991: H Ballentine Carter; Rachel F. Brem; C M Tempany; ANDREW YANG; Jonathan I Epstein; Patrick C Walsh; Robert Harriman
Nonpalpable prostate cancer: detection with MR imaging.
Radiology 1991;178(2):523-5.
1991: Alan W Partin; J E Oesterling; Jonathan I Epstein; R Horton; Patrick C Walsh
Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
The Journal of urology 1991;145(2):405-9.
1991: B S Carter; Gary D Steinberg; Terri H beaty; Barton Childs; Patrick C Walsh
Familial risk factors for prostate cancer.
Cancer surveys 1991;11():5-13.
1990: Gary D Steinberg; Jonathan I Epstein; Steven Piantadosi; Patrick C Walsh
Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.
The Journal of urology 1990;144(6):1425-32.
1990: Charles B Brendler; Gary D Steinberg; Fray F Marshall; Jacek L Mostwin; Patrick C Walsh
Local recurrence and survival following nerve-sparing radical cystoprostatectomy.
The Journal of urology 1990;144(5):1137-40; discussion 1140-1.
1990: Ulrike M Hamper; SHIELA SHETH; Patrick C Walsh; P M Holtz; Jonathan I Epstein
Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle.
AJR. American journal of roentgenology 1990;155(5):1015-9.
1990: H Ballentine Carter; Alan W Partin; Jonathan I Epstein; Daniel W Chan; Patrick C Walsh
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
The Journal of urology 1990;144(5):1167-70; discussion 1170-1.
1990: M D Rifkin; Robert Harriman; C A Gatsonis; Leslie E Quint; D M Paushter; Jonathan I Epstein; Ulrike M Hamper; Patrick C Walsh; B J McNeil
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.
The New England journal of medicine 1990;323(10):621-6.
1990: Patrick C Walsh; D M Quinlan; Ronald A Morton; M S Steiner
Radical retropubic prostatectomy. Improved anastomosis and urinary continence.
The Urologic clinics of North America 1990;17(3):679-84.
1990: Charles B Brendler; P N Schlegel; Patrick C Walsh
Urethrectomy with preservation of potency.
The Journal of urology 1990;144(2 Pt 1):270-3.
1990: Ulrike M Hamper; SHIELA SHETH; Patrick C Walsh; Jonathan I Epstein
Bright echogenic foci in early prostatic carcinoma: sonographic and pathologic correlation.
Radiology 1990;176(2):339-43.
1990: John P Gearhart; Patricia A Donohoue; Terry R Brown; Patrick C Walsh; Gary D Berkovitz
Endocrine evaluation of adults with mild hypospadias.
The Journal of urology 1990;144(2 Pt 1):274-7.
1990: Donald S Coffey; Patrick C Walsh
Clinical and experimental studies of benign prostatic hyperplasia.
The Urologic clinics of North America 1990;17(3):461-75.
1990: Ulrike M Hamper; Jonathan I Epstein; SHIELA SHETH; Patrick C Walsh; R C Sanders
Cystic lesions of the prostate gland. A sonographic--pathologic correlation.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1990;9(7):395-402.
1990: Patrick C Walsh; J E Oesterling
Improved hemostasis during simple retropubic prostatectomy.
The Journal of urology 1990;143(6):1203-4.
1990: Patrick C Walsh; C B Brendler; T Chang; F F Marshall; Jacek L Mostwin; R Stutzman; P N Schlegel
Preservation of sexual function in men during radical pelvic surgery.
Maryland medical journal (Baltimore, Md. : 1985) 1990;39(4):389-93.
1990: Alan W Partin; H Ballentine Carter; Daniel W Chan; Jonathan I Epstein; J E Oesterling; R C Rock; J P Weber; Patrick C Walsh
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
The Journal of urology 1990;143(4):747-52.
1990: W N Christensen; Alan W Partin; Patrick C Walsh; Jonathan I Epstein
Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage.
Cancer 1990;65(4):1021-7.
1990: Patrick C Walsh
Radical prostatectomy in locally confined prostatic carcinoma.
Progress in clinical and biological research 1990;359():199-207; discussion 223-9.
1990: Gary D Steinberg; B S Carter; Terri H beaty; Barton Childs; Patrick C Walsh
Family history and the risk of prostate cancer.
The Prostate 1990;17(4):337-47.
1990: Patrick C Walsh
Prostate carcinoma-current status and future direction.
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 1990;81(13 Suppl):1978-9.
1989: H Ballentine Carter; Ulrike M Hamper; SHIELA SHETH; R C Sanders; Jonathan I Epstein; Patrick C Walsh
Evaluation of transrectal ultrasound in the early detection of prostate cancer.
The Journal of urology 1989;142(4):1008-10.
1989: P N Schlegel; Patrick C Walsh
The use of the preperitoneal approach for the simultaneous repair of inguinal hernia during surgery on the bladder and prostate.
World journal of surgery 1989;13(5):555-9.
1989: James L Mohler; Y S Erozan; Patrick C Walsh; Jonathan I Epstein
Fine-needle core and aspiration biopsy. A new method for diagnosis of prostatic carcinoma.
Cancer 1989;63(9):1846-55.
1989: Richard B Alexander; Maureen G Maguire; Jonathan I Epstein; Patrick C Walsh
Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate.
The Journal of urology 1989;141(4):880-2.
1989: J P Weber; J E Oesterling; C A Peters; Alan W Partin; Daniel W Chan; Patrick C Walsh
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.
The Journal of urology 1989;141(4):987-92.
1989: D M Quinlan; Randy J Nelson; Alan W Partin; Jacek L Mostwin; Patrick C Walsh
The rat as a model for the study of penile erection.
The Journal of urology 1989;141(3):656-61.
1989: Alan W Partin; Jonathan I Epstein; Kathleen R Cho; A M Gittelsohn; Patrick C Walsh
Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.
The Journal of urology 1989;141(2):341-5.
1989: H Lepor; A W Kimball; Patrick C Walsh
Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.
The Journal of urology 1989;141(1):82-4.
1989: Patrick C Walsh; J E Oesterling; Jonathan I Epstein; Debra J Bruzek; R C Rock; Daniel W Chan
The value of prostate-specific antigen in the management of localized prostatic cancer.
Progress in clinical and biological research 1989;303():27-33.
1988: Patrick C Walsh; P N Schlegel
Radical pelvic surgery with preservation of sexual function.
Annals of surgery 1988;208(4):391-400.
1988: Patrick C Walsh
Nerve sparing radical prostatectomy for early stage prostate cancer.
Seminars in oncology 1988;15(4):351-8.
1988: Fray F Marshall; F Weiskopf; A Singh; F Mark; F Leo; R Sanders; R Makofski; Patrick C Walsh; N Smith
A prototype device for nonimmersion shock wave lithotripsy using ultrasonography for calculus localization.
The Journal of urology 1988;140(2):249-53.
1988: Jonathan I Epstein; J E Oesterling; Patrick C Walsh
Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.
The Journal of urology 1988;139(5):980-4.
1988: Jonathan I Epstein; J E Oesterling; Patrick C Walsh
The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer.
The Journal of urology 1988;139(5):975-9.
1988: Patrick C Walsh
The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia.
The Journal of urology 1988;139(4):826.
1988: J E Oesterling; Daniel W Chan; Jonathan I Epstein; A W Kimball; Debra J Bruzek; R C Rock; C B Brendler; Patrick C Walsh
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
The Journal of urology 1988;139(4):766-72.
1988: Patrick C Walsh
Radical retropubic prostatectomy with reduced morbidity: an anatomic approach.
NCI monographs : a publication of the National Cancer Institute 1988;(7):133-7.
1988: H Lepor; Patrick C Walsh
Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital.
NCI monographs : a publication of the National Cancer Institute 1988;(7):117-22.
1988: Patrick C Walsh
Preservation of sexual function in the surgical treatment of prostatic cancer--an anatomic surgical approach.
Important advances in oncology 1988;():161-70.
1987: Patrick C Walsh
Adjuvant radiotherapy after radical prostatectomy: is it indicated?
The Journal of urology 1987;138(6):1427-8.
1987: P N Schlegel; Patrick C Walsh
Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.
The Journal of urology 1987;138(6):1402-6.
1987: R C Rock; Daniel W Chan; Debra J Bruzek; C Waldron; J Oesterling; Patrick C Walsh
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
Clinical chemistry 1987;33(12):2257-61.
1987: Patrick C Walsh
Radical prostatectomy, preservation of sexual function, cancer control. The controversy.
The Urologic clinics of North America 1987;14(4):663-73.
1987: Patrick C Walsh; Jonathan I Epstein; F C Lowe
Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle.
The Journal of urology 1987;138(4):823-7.
1987: Daniel W Chan; Debra J Bruzek; J E Oesterling; R C Rock; Patrick C Walsh
Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.
Clinical chemistry 1987;33(10):1916-20.
1987: C A Peters; Patrick C Walsh
The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.
The New England journal of medicine 1987;317(10):599-604.
1987: Patrick C Walsh; H Lepor
The role of radical prostatectomy in the management of prostatic cancer.
Cancer 1987;60(3 Suppl):526-37.
1987: J E Oesterling; C B Brendler; Jonathan I Epstein; A W Kimball; Patrick C Walsh
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
The Journal of urology 1987;138(1):92-8.
1987: P N Schlegel; Patrick C Walsh
Simultaneous preperitoneal hernia repair during radical pelvic surgery.
The Journal of urology 1987;137(6):1180-3.
1987: J E Oesterling; Jonathan I Epstein; Patrick C Walsh
Long-term autopsy findings following radical prostatectomy.
Urology 1987;29(6):584-8.
1987: H Lepor; Patrick C Walsh
The role of radical prostatectomy in the management of stage B adenocarcinoma of the prostate.
Progress in clinical and biological research 1987;243B():343-56.
1987: Evelyn Barrack; C B Brendler; Patrick C Walsh
Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
Progress in clinical and biological research 1987;243A():79-97.
1986: Jonathan I Epstein; J E Oesterling; J C Eggleston; Patrick C Walsh
Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens.
The Journal of urology 1986;136(6):1234-7.
1986: J E Oesterling; Jonathan I Epstein; Patrick C Walsh
The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism.
The Journal of urology 1986;136(5):1030-4.
1986: Jonathan I Epstein; G Paull; J C Eggleston; Patrick C Walsh
Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
The Journal of urology 1986;136(4):837-9.
1986: Ulrike M Hamper; W F Dahnert; J C Eggleston; Patrick C Walsh; R C Sanders
Ultrasonography of prostatic carcinoma employing amplitude-enveloped (AM) and frequency-demodulated (FM) imaging: in vivo, in vitro, and pathologic correlation.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1986;5(10):557-62.
1986: Jonathan P Jarow; Gary D Berkovitz; Claude J Migeon; John P Gearhart; Patrick C Walsh
Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism.
The Journal of urology 1986;136(1 Pt 2):277-9.
1986: M C Benson; Patrick C Walsh
The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer: preliminary results.
The Journal of urology 1986;135(6):1194-8.
1986: W F Dähnert; Ulrike M Hamper; Patrick C Walsh; J C Eggleston; R C Sanders
The echogenic focus in prostatic sonograms, with xeroradiographic and histopathologic correlation.
Radiology 1986;159(1):95-100.
1986: Patrick C Walsh
Fine needle aspiration of the prostate--why has it taken so long to accept?
The Journal of urology 1986;135(2):334-5.
1986: W F Dähnert; Ulrike M Hamper; J C Eggleston; Patrick C Walsh; R C Sanders
Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma.
Radiology 1986;158(1):97-102.
1985: J C Eggleston; Patrick C Walsh
Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases.
The Journal of urology 1985;134(6):1146-8.
1985: M J Droller; Patrick C Walsh
Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
The Journal of urology 1985;134(6):1115-7.
1985: C A Peters; Patrick C Walsh
Blood transfusion and anesthetic practices in radical retropubic prostatectomy.
The Journal of urology 1985;134(1):81-3.
1985: H Lepor; M Gregerman; R Crosby; F K Mostofi; Patrick C Walsh
Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis.
The Journal of urology 1985;133(2):207-12.
1984: Patrick C Walsh; Jacek L Mostwin
Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique.
British journal of urology 1984;56(6):694-7.
1984: S J Berry; Donald S Coffey; Patrick C Walsh; L L Ewing
The development of human benign prostatic hyperplasia with age.
The Journal of urology 1984;132(3):474-9.
1984: F F Marshall; Patrick C Walsh
In situ management of renal tumors: renal cell carcinoma and transitional cell carcinoma.
The Journal of urology 1984;131(6):1045-9.
1984: C B Brendler; John T Isaacs; A L Follansbee; Patrick C Walsh
The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary report.
The Journal of urology 1984;131(4):694-700.
1984: Patrick C Walsh
Human benign prostatic hyperplasia: etiological considerations.
Progress in clinical and biological research 1984;145():1-25.
1983: Patrick C Walsh; Grover M Hutchins; L L Ewing
Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
The Journal of clinical investigation 1983;72(5):1772-7.
1983: M J Droller; Patrick C Walsh
Therapeutic efficacy of salvage cystectomy. Do results reflect natural history of bladder cancer?
Urology 1983;22(2):118-22.
1983: P Ekman; Evelyn Barrack; G L Greene; E V Jensen; Patrick C Walsh
Estrogen receptors in human prostate: evidence for multiple binding sites.
The Journal of clinical endocrinology and metabolism 1983;57(1):166-76.
1983: S L Kaufman; S Kadir; KLEMENS BARTH; J W Smyth; Patrick C Walsh; R I White
Mechanisms of recurrent varicocele after balloon occlusion or surgical ligation of the internal spermatic vein.
Radiology 1983;147(2):435-40.
1983: C B Brendler; S J Berry; L L Ewing; A R McCullough; R C Cochran; J D Strandberg; Barry R Zirkin; Donald S Coffey; L G Wheaton; M L Hiler; M J Bordy; G D Niswender; W W Scott; Patrick C Walsh
Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.
The Journal of clinical investigation 1983;71(5):1114-23.
1983: Evelyn Barrack; P Bujnovszky; Patrick C Walsh
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
Cancer research 1983;43(3):1107-16.
1983: Patrick C Walsh; H Lepor; J C Eggleston
Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations.
The Prostate 1983;4(5):473-85.
1983: John T Isaacs; C B Brendler; Patrick C Walsh
Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
The Journal of clinical endocrinology and metabolism 1983;56(1):139-46.
1982: P Ekman; Evelyn Barrack; Patrick C Walsh
Simultaneous measurement of progesterone and androgen receptors in human prostate: a microassay.
The Journal of clinical endocrinology and metabolism 1982;55(6):1089-99.
1982: Patrick C Walsh; P J Donker
Impotence following radical prostatectomy: insight into etiology and prevention.
The Journal of urology 1982;128(3):492-7.
1982: H Lepor; A Ross; Patrick C Walsh
The influence of hormonal therapy on survival of men with advanced prostatic cancer.
The Journal of urology 1982;128(2):335-40.
1982: L M Nyberg; W B Bias; Marc C Hochberg; Patrick C Walsh
Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.
The Journal of urology 1982;128(1):48-51.
1982: W B Bias; L M Nyberg; Marc C Hochberg; Patrick C Walsh
Peyronie's disease: a newly recognized autosomal-dominant trait.
American journal of medical genetics 1982;12(2):227-35.
1982: S M Goldman; OLGA GATEWOOD; Patrick C Walsh; A Dornhorst; Stanley S Siegelman
CT configuration of the enlarged adrenal gland.
Journal of computer assisted tomography 1982;6(2):276-80.
1982: J S Elder; H J Jewett; Patrick C Walsh
Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate.
The Journal of urology 1982;127(4):704-6.
1982: J Trachtenberg; Patrick C Walsh
Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer.
The Journal of urology 1982;127(3):466-71.
1982: J S Elder; John T Isaacs; Patrick C Walsh
Androgenic sensitivity of the gubernaculum testis: evidence for hormonal/mechanical interactions in testicular descent.
The Journal of urology 1982;127(1):170-6.
1982: J Trachtenberg; P Bujnovszky; Patrick C Walsh
Androgen receptor content of normal and hyperplastic human prostate.
The Journal of clinical endocrinology and metabolism 1982;54(1):17-21.
1981: P K Whelton; Andrew P Harris; R P Russell; Patrick C Walsh; GEORGE WILLIAMS; D P Harrington; W G Walker
Renovascular hypertension: results of medical and surgical therapy.
The Johns Hopkins medical journal 1981;149(6):213-9.
1981: Patrick C Walsh; R I White
Balloon occlusion of the internal spermatic vein for the treatment of varicoceles.
JAMA : the journal of the American Medical Association 1981;246(15):1701-2.
1981: Patrick C Walsh
Randomized study of prostatic cancer.
Urology 1981;18(2):219-20.
1981: R S Feinstein; OLGA GATEWOOD; S M Goldman; B Copeland; Patrick C Walsh; Stanley S Siegelman
Computerized tomography in the diagnosis of retroperitoneal fibrosis.
The Journal of urology 1981;126(2):255-9.
1981: R J Ehrlichman; S L Kaufman; Stanley S Siegelman; D L Trump; Patrick C Walsh
Computerized tomography and lymphangiography in staging testis tumors.
The Journal of urology 1981;126(2):179-81.
1981: K R Fichman; L M Nyberg; P Bujnovszky; Terry R Brown; Patrick C Walsh
The ontogeny of the androgen receptor in human foreskin.
The Journal of clinical endocrinology and metabolism 1981;52(5):919-23.
1981: R I White; S L Kaufman; KLEMENS BARTH; S Kadir; J W Smyth; Patrick C Walsh
Occlusion of varicoceles wih detachable balloons.
Radiology 1981;139(2):327-34.
1981: B B Cantrell; D P DeKlerk; J C Eggleston; J K Boitnott; Patrick C Walsh
Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade.
The Journal of urology 1981;125(4):516-20.
1981: J Trachtenberg; L L Hicks; Patrick C Walsh
Methods for the determination of androgen receptor content in human prostatic tissue.
Investigative urology 1981;18(5):349-54.
1981: N T Schmeller; Stanley S Siegelman; Patrick C Walsh
Anatomical considerations in suprahilar lymph node dissection for testicular tumors.
Urologia internationalis 1981;36(6):341-5.
1980: S S Howards; Patrick C Walsh
Radioimmunoassay for prostatic acid phosphatase.
The Journal of urology 1980;124(5):753-4.
1980: Patrick C Walsh
Radical prostatectomy for the treatment of localized prostatic carcinoma.
The Urologic clinics of North America 1980;7(3):583-91.
1980: N B Rosenshein; A S Lichter; Patrick C Walsh
Cervical cancer complicated by a pelvic kidney.
The Journal of urology 1980;123(5):766-7.
1980: J B Murphy; R C Emmott; L L Hicks; Patrick C Walsh
Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin: a marker for estrogen-responsive tissues?
The Journal of clinical endocrinology and metabolism 1980;50(5):938-48.
1980: J Trachtenberg; L L Hicks; Patrick C Walsh
Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
The Journal of clinical investigation 1980;65(5):1051-9.
1980: W W Scott; Mani Menon; Patrick C Walsh
Hormonal therapy of prostatic cancer.
Cancer 1980;45(7 Suppl):1929-36.
1980: Patrick C Walsh; H J Jewett
Radical surgery for prostatic cancer.
Cancer 1980;45(7 Suppl):1906-11.
1980: Robert Harriman; Stanley S Siegelman; Patrick C Walsh; R I White
Elevated pressure in the left renal vein in patients with varicocele: preliminary observations.
The Journal of urology 1980;123(4):512-3.
1979: P K Whelton; Andrew P Harris; R P Russell; Patrick C Walsh; GEORGE WILLIAMS; D P Harrington; W G Walker
Renovascular hypertension: comparison of medical and surgical therapy.
Clinical science (London, England : 1979) 1979;57 Suppl 5():445s-447s.
1979: Patrick C Walsh; T Hensle; H J Wigger
Ambiguous genitalia in a child.
Urology 1979;14(4):405-10.
1979: D P DeKlerk; Donald S Coffey; L L Ewing; I R McDermott; W G Reiner; C H Robinson; W W Scott; J D Strandberg; Paul Talalay; Patrick C Walsh; L G Wheaton; Barry R Zirkin
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.
The Journal of clinical investigation 1979;64(3):842-9.
1979: W G Reiner; W W Scott; J C Eggleston; Patrick C Walsh
Long-term survival after hormonal therapy for stage D prostatic cancer.
The Journal of urology 1979;122(2):183-4.
1979: H Lepor; Patrick C Walsh
Idiopathic retroperitoneal fibrosis.
The Journal of urology 1979;122(1):1-6.
1979: L L Hicks; Patrick C Walsh
A microassay for the measurement of androgen receptors in human prostatic tissue.
Steroids 1979;33(4):389-406.
1979: T F Davies; Patrick C Walsh; Gary Hodgen; M L Dufau; K J Catt
Characterization of the primate luteinizing hormone receptor in testis homogenates and Leydig cells.
The Journal of clinical endocrinology and metabolism 1979;48(4):680-5.
1979: Patrick C Walsh
A new cause of male infertility.
The New England journal of medicine 1979;300(5):253-4.
1979: W G Reiner; Patrick C Walsh
An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery.
The Journal of urology 1979;121(2):198-200.
1979: W D Heston; Mani Menon; C Tananis; Patrick C Walsh
Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor.
Cancer letters 1979;6(1):45-50.
1979: Patrick C Walsh; L L Hicks
Characterization and measurement of androgen receptors in human prostatic tissue.
Progress in clinical and biological research 1979;33():51-63.
1978: S J McPhee; R D Katz; J L Olson; Patrick C Walsh
Clinical conferences at the Johns Hopkins Hospital. Prostatic carcinoma.
The Johns Hopkins medical journal 1978;143(6):207-11.
1978: S Michigan; P K Whelton; Patrick C Walsh
Forgotten kidney: asynchronous bilateral ureteropelvic junction obstruction.
Urology 1978;12(5):565-6.
1978: Patrick C Walsh; J D Wilson; T D Allen; J D Madden; J C Porter; W B Neaves; J E Griffin; W E Goodwin
Clinical and endocrinological evaluation of patients with congenital microphallus.
The Journal of urology 1978;120(1):90-5.
1978: Patrick C Walsh; Claude J Migeon
The phenotypic expression of selective disorders of male sexual differentiation.
The Journal of urology 1978;119(5):627-9.
1978: J Rajfer; J C Eggleston; R C Sanders; Patrick C Walsh
Fever and prostatic mass in a young man.
The Journal of urology 1978;119(4):555-8.
1978: J Rajfer; G Mendelsohn; J Arnheim; R D Jeffs; Patrick C Walsh
Dysgenetic male pseudohermaphroditism.
The Journal of urology 1978;119(4):525-7.
1978: Patrick C Walsh
The differential diagnosis of ambiguous genitalia in the newborn.
The Urologic clinics of North America 1978;5(1):213-21.
1978: J Rajfer; Patrick C Walsh
Testicular descent. Normal and abnormal.
The Urologic clinics of North America 1978;5(1):223-35.
1978: Mani Menon; C E Tananis; L L Hicks; E F Hawkins; M G McLoughlin; Patrick C Walsh
Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
The Journal of clinical investigation 1978;61(1):150-62.
1977: R C Sanders; T Duffy; M G Mcloughlin; Patrick C Walsh
Sonography in the diagnosis of retroperitoneal fibrosis.
The Journal of urology 1977;118(6):944-6.
1977: J Rajfer; Patrick C Walsh
Hormonal regulation of testicular descent: experimental and clinical observations.
The Journal of urology 1977;118(6):985-90.
1977: J A Amrhein; G J Klingensmith; Patrick C Walsh; Victor A McKusick; Claude J Migeon
Partial androgen insensitivity: the Reifenstein syndrome revisited.
The New England journal of medicine 1977;297(7):350-6.
1977: F F Marshall; Patrick C Walsh
Extrarenal manifestations of renal cell carcinoma.
The Journal of urology 1977;117(4):439-40.
1977: Mani Menon; C E Tananis; M G McLoughlin; Marc Lippman; Patrick C Walsh
The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay.
The Journal of urology 1977;117(3):309-12.
1977: Mani Menon; C E Tananis; M G McLoughlin; Patrick C Walsh
Androgen receptors in human prostatic tissues: a review.
Cancer treatment reports 1977;61(2):265-71.
1977: J Rajfer; Donald S Coffey; Patrick C Walsh
Effects of hormones in the newborn period on the development of the penis.
Surgical forum 1977;28():570-3.
1977: Patrick C Walsh
The endocrinology of testicular tumors.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1977;(60):196-201.
1977: Patrick C Walsh; J M Greco; C E Tananis; L L Hicks; M G McLoughlin; Mani Menon
The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
Transactions of the American Association of Genito-Urinary Surgeons 1977;69():78-80.
1977: J Rajfer; Patrick C Walsh
Testicular descent.
Birth defects original article series 1977;13(2):107-22.
1976: J Rajfer; Patrick C Walsh
The incidence of intersexuality in patients with hypospadias and cryptorchidism.
The Journal of urology 1976;116(6):769-70.
1976: H R Clyde; Patrick C Walsh; R W English
Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism.
Fertility and sterility 1976;27(6):662-6.
1976: Patrick C Walsh; J D Wilson
The induction of prostatic hypertrophy in the dog with androstanediol.
The Journal of clinical investigation 1976;57(4):1093-7.
1976: W R Sloan; Patrick C Walsh
Familial persistent Müllerian duct syndrome.
The Journal of urology 1976;115(4):459-61.
1976: Patrick C Walsh; M G McLoughlin; Mani Menon; C Tananis
Measurement of androgen receptors in human prostatic tissue: methodological considerations.
Progress in clinical and biological research 1976;6():159-68.
1976: Patrick C Walsh
Benign prostatic hyperplasia: etiological considerations.
Progress in clinical and biological research 1976;6():1-8.
1976: Patrick C Walsh; N Curry; R C Mills; Pentti Siiteri
Plasma androgen responce to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism.
The Journal of clinical endocrinology and metabolism 1976;42(1):52-9.
1975: K J Catt; M L Dufau; W B Neaves; Patrick C Walsh; J D Wilson
LH-hCG receptors and testosterone content during differentiation of the testis in the rabbit embryo.
Endocrinology 1975;97(5):1157-65.
1975: J S Cochran; Patrick C Walsh; J C Porter; T C Nicholson; J D Madden; P C Peters
The endocrinology of human chorionic gonadotropin-secreting testicular tumors: new methods in diagnosis.
The Journal of urology 1975;114(4):549-55.
1975: R S Swerdloff; Patrick C Walsh
Pituitary and gonadal hormones in patients with varicocele.
Fertility and sterility 1975;26(10):1006-12.
1975: J D Madden; Patrick C Walsh; P C MacDonald; J D Wilson
Clinical and endocrinologic characterization of a patients with the syndrome of incomplete testicular feminization.
The Journal of clinical endocrinology and metabolism 1975;41(4):751-60.
1975: Patrick C Walsh; Pentti Siiteri
Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.
The Journal of urology 1975;114(2):254-6.
1975: Patrick C Walsh
Physiologic basis for hormonal theapy in carcinoma of the prostate.
The Urologic clinics of North America 1975;2(1):125-40.
1974: Patrick C Walsh; J D Madden; M J Harrod; J L Goldstein; P C MacDonald; J D Wilson
Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.
The New England journal of medicine 1974;291(18):944-9.
1974: T C Nicholson; Patrick C Walsh; M B Rotner
Lymphadenectomy combined with preoperative and postoperative cobalt 60 teletherapy in the management of embryonal carcinoma and teratocarcinoma of the testis.
The Journal of urology 1974;112(1):109-10.
1974: D R Hill; Q E Crews; Patrick C Walsh
Prostate carcinoma: radiation treatment of the primary and regional lymphatics.
Cancer 1974;34(1):156-60.
1974: S C Henry; Patrick C Walsh; M B Rotner
Choriocarcinoma of the testis.
The Journal of urology 1974;112(1):105-8.
1974: J S Cochran; Patrick C Walsh; J C Porter; T P Nicholson; P C Peters
Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.
Surgical forum 1974;25(0):542-3.
1973: J R Piconi; S C Henry; Patrick C Walsh
Rapid development of carcinoma in diverticulum of the bladder. A pitfall in conservative management.
Urology 1973;2(6):676-7.
1973: Patrick C Walsh; R S Swerdloff; W D Odell
Feedback control of FSH in the male: role of oestrogen.
Acta endocrinologica 1973;74(3):449-60.
1973: Patrick C Walsh; R S Swerdloff
Biphasic effect of testosterone on spermatogenesis in the rat.
Investigative urology 1973;11(3):190-3.
1973: G Khudr; Patrick C Walsh; K Benirschke
Quinacrine fluorescence of testicular tumors.
Urology 1973;2(2):162-4.
1973: Patrick C Walsh; R S Swerdloff; W D Odell
Feedback regulation of gonadotropin secretion in men.
The Journal of urology 1973;110(1):84-9.
1973: R B Smith; Patrick C Walsh; W E Goodwin
Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
The Journal of urology 1973;110(1):106-8.
1973: Patrick C Walsh; J J Kaufman; R B Smith; W E Goodwin
Percutaneous antegrade pyelography in hydronephrosis. Preoperative assessment.
Urology 1973;1(6):537-41.
1973: J Saalfeld; Patrick C Walsh; W E Goodwin
Ureterovaginoplasty for vaginal atresia (unique technique in treatment): a case report with description of associated arterial anomalies and retroiliac artery ureters.
The Journal of urology 1973;109(6):1039-45.
1973: R S Swerdloff; Patrick C Walsh
Testosterone and oestradiol suppression of LH and FSH in adult male rats: duration of castration, duration of treatment and combined treatment.
Acta endocrinologica 1973;73(1):11-21.
1973: N L Constantinople; Patrick C Walsh
Activity of müllerian-inhibiting substance in postnatal testes.
Surgical forum 1973;24():538-9.
1973: Patrick C Walsh; R S Swerdloff
Experimental cryptorchism: effect on serum LH and FSH in the rat.
Urological research 1973;1(1):22-6.
1972: R S Swerdloff; Patrick C Walsh; W D Odell
Control of LH and FSH secretion in the male: Evidence that aromatization of androgens to estradiol is not required for inhibition of gonadotropin secretion.
Steroids 1972;20(1):13-22.
1972: Patrick C Walsh; R S Swerdloff; W D Odell
Cyproterone: effect on serum gonadotropins in the male.
Endocrinology 1972;90(6):1655-9.
1972: Patrick C Walsh; R S Swerdloff
Testosterone: effect on rat testis.
Surgical forum 1972;23(0):522-3.
1971: Patrick C Walsh; J J Kaufman; W F Coulson; W E Goodwin
Retroperitoneal lymphadenectomy for testicular tumors.
JAMA : the journal of the American Medical Association 1971;217(3):309-12.
1971: Patrick C Walsh; S G Korenman
Mechanism of androgenic action: effect of specific intracellular inhibitors.
The Journal of urology 1971;105(6):850-7.
1971: R S Swerdloff; Patrick C Walsh; H S Jacobs; W D Odell
Serum LH and FSH during sexual maturation in the male rat: effect of castration and cryptorchidism.
Endocrinology 1971;88(1):120-8.
1970: Patrick C Walsh; R F Gittes; J W Lecky
Aortography in experimental renal failure. Evaluation of contrast media toxicity.
Radiology 1970;97(1):33-7.
1970: Patrick C Walsh; R F Gittes
Inhibition of extratesticular stimuli to prostatic growth in the castrate rat by antiandrogens.
Endocrinology 1970;87(3):624-7.
1970: Patrick C Walsh; R S Swerdloff; W D Odell
Cryptorchism: effect on pituitary gonadotropin secretion in the rat.
Surgical forum 1970;21():530-2.
1969: Patrick C Walsh; R F Gittes
Inhibition by antiandrogens of the prostatic growth stimulated by adrenal androgens and pituitary prolactin in castrate rats.
Surgical forum 1969;20():518-9.